===========================================================================


                                UNITED STATES
                     SECURITIES AND EXCHANGE COMMISSION
                           WASHINGTON, D.C.  20549

                            ____________________

                                  FORM 10-Q

            [X]  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
                   OF THE SECURITIES EXCHANGE ACT OF 1934

                For the Quarterly Period Ended March 31, 2005

           [ ]  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
                   OF THE SECURITIES EXCHANGE ACT OF 1934

                 For the Transition Period from ____ to ____

                            ____________________

                         Commission File No. 0-12942

                             PARLEX CORPORATION
           (Exact Name of Registrant as Specified in Its Charter)

            Massachusetts                            04-2464749
      ------------------------                       -----------
      (State of incorporation)                       (I.R.S. ID)

               One Parlex Place, Methuen, Massachusetts  01844
            (Address of Principal Executive Offices)  (Zip Code)

                                978-685-4341
            (Registrant's Telephone Number, Including Area Code)

Indicate by check mark whether the registrant (1) has filed all reports 
required to be filed by Section 13 or 15(d) of the Securities Exchange Act 
of 1934 during the preceding 12 months (or for such shorter period that the 
registrant was required to file such reports), and (2) has been subject to 
such filing requirements for the past 90 days.      Yes  [X]      No  [ ]

Indicate by check mark whether the registrant is an accelerated filer (as 
defined in Rule 12b-2 of the Exchange Act).
Yes  [ ]      No  [X]

The number of shares outstanding of the registrant's common stock as of May 
9, 2005 was 6,475,302 shares.

===========================================================================


  


                             PARLEX CORPORATION
                             ------------------

                                 FORM 10 - Q
                                 -----------

                                    INDEX
                                    -----

Part I - Financial Information                                         Page
                                                                       ----

Item 1.  Unaudited Condensed Consolidated Financial Statements:

         Condensed Consolidated Balance Sheets - March 31, 2005 and
         June 30, 2004                                                    3

         Condensed Consolidated Statements of Operations - For the
         Three and Nine Months Ended March 31, 2005 and March 28, 2004    4

         Condensed Consolidated Statements of Cash Flows - For the
         Nine Months Ended March 31, 2005 and March 28, 2004              5

         Notes to Unaudited Condensed Consolidated Financial Statements   6

Item 2.  Management's Discussion and Analysis of Financial Condition
         and Results of Operations                                       20

Item 3.  Quantitative and Qualitative Disclosures About Market Risk      40

Item 4.  Controls and Procedures                                         40

Part II - Other Information

Item 3.  Defaults Upon Senior Securities                                 42

Item 6.  Exhibits                                                        42

Signatures                                                               43

Exhibit Index                                                            44


  2


PARLEX CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited)
---------------------------------------------------------------------------




ASSETS                                                    March 31, 2005    June 30, 2004

                                                                      
CURRENT ASSETS:
  Cash and cash equivalents                                $  3,940,821     $  1,626,275
  Accounts receivable - net                                  21,731,710       21,999,646
  Inventories - net                                          23,182,945       20,326,134
  Refundable income taxes                                        38,602          380,615
  Deferred income taxes                                          42,958           42,958
  Other current assets                                        2,462,462        2,381,471
                                                           ------------     ------------

      Total current assets                                   51,399,498       46,757,099
                                                           ------------     ------------

PROPERTY, PLANT AND EQUIPMENT - NET                          42,681,911       44,979,740

INTANGIBLE ASSETS - NET                                          30,550           32,746

GOODWILL - NET                                                1,157,510        1,157,510

DEFERRED INCOME TAXES                                            40,000           40,000

OTHER ASSETS - NET                                            1,781,888        2,283,136
                                                           ------------     ------------

TOTAL                                                      $ 97,091,357     $ 95,250,231
                                                           ============     ============

LIABILITIES AND STOCKHOLDERS' EQUITY

CURRENT LIABILITIES:
  Current portion of long-term debt                        $ 14,341,766     $ 12,861,077
  Accounts payable                                           17,186,468       16,479,547
  Dividends payable                                              66,113           39,317
  Accrued liabilities                                         5,251,594        4,277,587
                                                           ------------     ------------

      Total current liabilities                              36,845,941       33,657,528
                                                           ------------     ------------

LONG-TERM DEBT                                               13,466,033           10,534
                                                           ------------     ------------

OTHER NONCURRENT LIABILITIES                                    831,027        1,025,091
                                                           ------------     ------------

MINORITY INTEREST IN PARLEX SHANGHAI                            687,971          570,963
                                                           ------------     ------------

COMMITMENTS AND CONTINGENCIES
  STOCKHOLDERS' EQUITY:
  Preferred stock, $1.00 par value - 1,000,000 shares
   authorized; 40,625 shares issued and outstanding              40,625           40,625
  Common stock, $.10 par value - 30,000,000 shares
   authorized; 6,462,179 shares issued and outstanding
   at March 31, 2005; 6,632,810 shares issued and
   6,422,810 shares outstanding at June 30, 2004                646,218          663,281
  Accrued interest payable in common stock                       83,331           87,924
  Additional paid-in capital                                 66,012,012       66,979,397
  Accumulated deficit                                       (22,293,392)     (17,771,307)
  Accumulated other comprehensive income                        771,591          499,675
  Less treasury stock, at cost                                        -       (1,037,625)
                                                           ------------     ------------

      Total stockholders' equity                             45,260,385       49,461,970
                                                           ------------     ------------

TOTAL                                                      $ 97,091,357     $ 95,250,231
                                                           ============     ============


See notes to unaudited condensed consolidated financial statements.


  3


PARLEX CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited)
---------------------------------------------------------------------------




                                                         Three Months Ended                   Nine Months Ended
                                                  March 31, 2005    March 28, 2004    March 31, 2005    March 28, 2004
                                                  --------------    --------------    --------------    --------------

                                                                                              
REVENUES:                                           $29,132,080       $23,164,660       $90,822,846       $66,428,184

COSTS AND EXPENSES:
  Cost of products sold                              26,502,577        21,258,693        79,527,348        59,536,501
  Selling, general and administrative expenses        4,119,467         3,817,667        13,338,451        11,517,407
                                                    -----------       -----------       -----------       -----------

      Total costs and expenses                       30,622,044        25,076,360        92,865,799        71,053,908
                                                    -----------       -----------       -----------       -----------

OPERATING LOSS                                       (1,489,964)       (1,911,700)       (2,042,953)       (4,625,724)

INTEREST INCOME (EXPENSE)
Interest income                                          16,935             2,031            56,803             9,052
Interest expense                                       (761,781)         (642,173)       (2,298,468)       (1,839,678)
                                                    -----------       -----------       -----------       -----------

LOSS BEFORE INCOME TAXES
AND MINORITY INTEREST                                (2,234,810)       (2,551,842)       (4,284,618)       (6,456,350)

PROVISION FOR INCOME TAXES                               (4,754)          (47,858)         (120,460)          (47,858)
                                                    -----------       -----------       -----------       -----------

LOSS BEFORE MINORITY INTEREST                        (2,239,564)       (2,599,700)       (4,405,078)       (6,504,208)

MINORITY INTEREST                                       (36,110)            9,624          (117,008)         (100,133)
                                                    -----------       -----------       -----------       -----------

NET LOSS                                             (2,275,674)       (2,590,076)       (4,522,086)       (6,604,341)

PREFERRED STOCK DIVIDENDS                               (66,113)                -          (201,279)                -
                                                    -----------       -----------       -----------       -----------

NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS        $(2,341,787)      $(2,590,076)      $(4,723,365)      $(6,604,341)
                                                    ===========       ===========       ===========       ===========

BASIC AND DILUTED NET LOSS PER SHARE                $     (0.36)      $     (0.40)      $     (0.73)      $     (1.04)
                                                    ===========       ===========       ===========       ===========

WEIGHTED AVERAGE SHARES - BASIC AND DILUTED           6,461,887         6,409,110         6,448,864         6,351,243
                                                    ===========       ===========       ===========       ===========


See notes to unaudited condensed consolidated financial statements.


  4


PARLEX CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)
---------------------------------------------------------------------------




                                                                                   Nine Months Ended
                                                                           March 31, 2005     March 28, 2004
                                                                           --------------     --------------

                                                                                        
CASH FLOWS FROM OPERATING ACTIVITIES:
  Net loss                                                                 $ (4,522,086)      $ (6,604,341)
                                                                           ------------       ------------
  Adjustments to reconcile net loss to net cash
   provided by (used in) operating activities:
    Non-cash operating items:
      Depreciation of property, plant and equipment                           4,086,373          4,127,103
      Amortization of deferred loss on sale-leaseback,
       deferred financing costs and intangible assets                           855,252            749,546 
      Interest payable in common stock                                          249,862            254,948 
      Minority interest                                                         117,008            100,133 
      Gain on sale of China land use rights                                           -            (86,531)
      Changes in current assets and liabilities:
        Accounts receivable - net                                               368,648         (2,991,203)
        Inventories - net                                                    (2,776,479)        (2,739,505)
        Refundable income taxes                                                 367,328            144,776 
        Other assets                                                            371,657           (819,826)
        Accounts payable and accrued liabilities                               (580,750)        (1,339,997)
                                                                           ------------       ------------
          Net cash used in operating activities                              (1,463,187)        (9,204,897)
                                                                           ------------       ------------

CASH FLOWS FROM INVESTING ACTIVITIES:
  Sale of China land use rights                                                       -          1,179,145 
  Additions to property, plant and equipment and other assets                  (706,752)          (484,485)
                                                                           ------------       ------------
          Net cash (used in) provided by investing activities                  (706,752)           694,660
                                                                           ------------       ------------

CASH FLOWS FROM FINANCING ACTIVITIES:
  Exercise of warrants                                                                -            600,000 
  Proceeds from bank loans                                                   76,328,433         46,430,209 
  Payment of bank loans                                                     (74,848,723)       (43,167,484)
  Payment of capital lease                                                      (80,401)            (9,104)
  Payment of Methuen sale-leaseback financing obligation                       (168,797)          (229,452)
  Cash received for interest on sale-leaseback note receivable                   85,372             99,378 
  Proceeds from sale-leaseback note receivable                                1,900,000                  - 
  Proceeds from sale-leaseback earnout provision                                275,000                  - 
  Proceeds from other notes, payable                                            179,249                  - 
  Repayment of other notes, payable                                             (46,391)                 - 
  Dividend paid to series A preferred stock investors                          (174,482)                 - 
  Receipt of joint venture deposit                                            1,000,000                  - 
  Proceeds from convertible note, net of costs                                        -          5,472,002 
                                                                           ------------       ------------
          Net cash provided by financing activities                           4,449,260          9,195,549
                                                                           ------------       ------------

EFFECT OF EXCHANGE RATE CHANGES ON CASH                                          35,225             43,109 
                                                                           ------------       ------------

NET INCREASE IN CASH AND CASH EQUIVALENTS                                     2,314,546            728,421 

CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR                                  1,626,275          1,513,523 
                                                                           ------------       ------------

CASH AND CASH EQUIVALENTS, END OF PERIOD                                   $  3,940,821       $  2,241,944 
                                                                           ============       ============

SUPPLEMENTARY DISCLOSURE OF NONCASH FINANCING AND
INVESTING ACTIVITIES:
  Property, plant, equipment and other asset purchases
   financed under capital lease, long-term debt and
   accounts payable                                                        $    952,493       $  1,696,044 
                                                                           ============       ============
  Issuance of warrants in connection with issuance of convertible debt     $          -       $  1,139,252 
                                                                           ============       ============
  Beneficial conversion feature associated with convertible debt           $          -       $  1,035,016 
                                                                           ============       ============
  Interest paid in common stock                                            $    254,456       $    254,948 
                                                                           ============       ============
Sale-leaseback earnout proceeds placed in escrow                           $    400,000       $          - 
                                                                           ============       ============


See notes to unaudited condensed consolidated financial statements.


  5


PARLEX CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
---------------------------------------------------------------------------

1.    Basis of Presentation
      ---------------------

      The condensed consolidated financial statements include the accounts 
      of Parlex Corporation, its wholly owned subsidiaries ("Parlex" or the 
      "Company") and its 90.1% investment in Parlex (Shanghai) Circuit Co., 
      Ltd. ("Parlex Shanghai"). The financial statements as reported in 
      Form 10-Q reflect all adjustments that are, in the opinion of 
      management, necessary to present fairly the financial position as of 
      March 31, 2005 and the results of operations and cash flows for the 
      three and nine months ended March 31, 2005 and March 28, 2004.  All 
      adjustments made to the interim financial statements included all 
      those of a normal and recurring nature.  The results for interim 
      periods are not necessarily indicative of results that may be 
      expected for any other interim period or for the full year.

      This filing should be read in conjunction with the Company's annual 
      report on Form 10-K for the year ended June 30, 2004.

      As shown in the condensed consolidated financial statements, the 
      Company incurred net losses of $4,522,086 and $6,604,341 and used cash 
      of $1,463,187 and $9,204,897 in operations for the nine months ended 
      March 31, 2005 and March 28, 2004, respectively.  In addition, the 
      Company had an accumulated deficit of $22,293,392 at March 31, 2005.  
      As of March 31, 2005, the Company had a cash balance of $3,940,821.

      In response to the worldwide downturn in the electronics industry, 
      management has taken a series of actions to reduce operating expenses 
      and to restructure operations, consisting primarily of reductions in 
      workforce and consolidation of manufacturing operations.  During 
      2004, the Company transferred its high volume automated surface mount 
      assembly line from its Cranston, Rhode Island facility to China.  In 
      August 2004, the Company announced a new strategic relationship with 
      Delphi Corporation to supply all multilayer flex and rigid flex 
      circuits that were previously manufactured by Delphi Corporation in 
      its Irvine, California facility.  Management continues to implement 
      plans to control operating expenses, inventory levels, and capital 
      expenditures as well as manage accounts payable and accounts 
      receivable to enhance cash flow and return the Company to 
      profitability. Management's plans include the following actions: 1) 
      continuing to consolidate manufacturing facilities; 2) continuing to 
      transfer certain manufacturing processes from the Company's domestic 
      operations to lower cost international manufacturing locations, 
      primarily those in the People's Republic of China; 3) expanding the 
      Company's products in the home appliance, cell phone and handheld 
      devices, medical, military and aerospace, and electronic 
      identification markets; 4) continuing to monitor general and 
      administrative expenses; and 5) continuing to evaluate opportunities 
      to improve capacity utilization by either acquiring multilayer 
      flexible circuit businesses or entering into strategic relationships 
      for their production.

      In fiscal years 2003 and 2004, management entered into a series of 
      alternative financing arrangements to partially replace or supplement 
      those currently in place in order to provide the Company with 
      financing to support its current working capital needs.  Working 
      capital requirements, particularly those to support the growth in the 
      Company's China operations, consumed $10.4 million of a total $11.4 
      million of cash used in operations during 2004.  In September 2004, 
      the Company secured a new $5 million asset based working capital 
      agreement with the Bank of China which provides standalone financing 
      for its China operations. In addition, in May and June of 2004 the 
      Company received net proceeds of approximately $2.95 million from the 
      sale of its Series A convertible preferred stock. In December 2004, 
      the Company entered into a joint venture agreement and related 
      agreements with Infineon Technologies Asia Pacific Pte Ltd.  The 
      Company received a $1.0 million deposit upon execution of the 
      agreements, and will receive an additional $2.0 million once certain 
      People's Republic of China government approvals are received for the 
      new joint venture company and the transaction closes (see Note 14).  
      Also in December 2004, the Company executed a loan modification with 
      Silicon Valley Bank ("SVB") extending the term of its loan agreement 
      with SVB to July


  6


      2006 and increasing the borrowing limit from $10.0 million to $12.0 
      million.  In February 2005, the landlord for the Company's Methuen, 
      Massachusetts facility completed the sale of the property to a third 
      party.  Under the terms of the transaction, the Company received cash 
      of approximately $2.2 million.  The proceeds represented repayment of 
      the outstanding financing the Company originally provided under the 
      initial sale-leaseback transaction and a settlement of amounts due 
      under terms of an earn out provision (see Note 8).  During the first 
      nine months ended March 31, 2005, the Company used cash in operations 
      of approximately $1,463,000.  Management continues to evaluate 
      alternative financing opportunities to further improve its liquidity 
      and to fund working capital needs.  Management believes that the 
      Company's cash on hand and the cash expected to be generated from 
      operations will be sufficient to enable the Company to meet its 
      operating obligations at least through March 2006.  If the Company 
      requires additional or new external financing to repay or refinance 
      its existing financing obligations or fund its working capital 
      requirements, the Company believes that it will be able to obtain 
      such financing.  Failure to obtain such financing may have a material 
      adverse impact on the Company's operations.  At March 31, 2005, the 
      Company was not in compliance with certain financial covenants of its 
      loan agreement with SVB.  The Company has received a waiver from the 
      bank of its non-compliance at March 31, 2005 and the bank has continued 
      to allow the Company to borrow against the loan agreement. 

2.    Stock-Based Compensation
      ------------------------

      The Company accounts for stock-based compensation to employees and 
      nonemployee directors in accordance with Accounting Principles Board 
      Opinion No. 25 ("APB No. 25"), Accounting for Stock Issued to 
      Employees, using the intrinsic-value method as permitted by Statement 
      of Financial Accounting Standards No. 123 ("SFAS No. 123"), 
      Accounting for Stock-Based Compensation.  Under the intrinsic value 
      method, compensation associated with stock awards to employees and 
      directors is determined as the difference, if any, between the 
      current fair value of the underlying common stock on the date 
      compensation is measured and the price the employee or director must 
      pay to exercise the award.  The measurement date for employee awards 
      is generally the date of grant.

      Had the Company used the fair-value method to measure compensation, 
      the Company's net loss and basic and diluted net loss per share would 
      have been as follows:




                                                                   Three Months Ended                  Nine Months Ended
                                                            March 31, 2005    March 28, 2004    March 31, 2005    March 28, 2004

                                                                                                       
      Net loss attributable to common stockholders           $(2,341,787)      $(2,590,076)      $(4,723,365)      $(6,604,341)
      Add stock-based compensation expense
       included in reported net loss                                   -                 -                 -                 - 
      Deduct stock-based compensation expense
       determined under the fair-value method                    (96,000)         (158,000)         (276,000)         (520,000)
                                                             -----------       -----------       -----------       -----------
      Net loss - attributable to common stockholders - 
       pro forma                                             $(2,437,787)      $(2,748,076)      $(4,999,365)      $(7,124,341)
                                                             ===========       ===========       ===========       ===========

      Basic and diluted net loss per share - as reported     $     (0.36)      $     (0.40)      $     (0.73)      $     (1.04)
      Basic and diluted net loss per share - pro forma       $     (0.38)      $     (0.43)      $     (0.78)      $     (1.12)



  7


      The fair values of the options at the date of grant were estimated 
      using the Black-Scholes option pricing model with the following 
      assumptions:




                                                         Three Months Ended                     Nine Months Ended
                                                  March 31, 2005     March 28, 2004     March 31, 2005     March 28, 2004

                                                                                                 
      Average risk-free interest rate                    3.0%               3.3%               3.0%               3.5%
      Expected life of option grants                3.5 years          3.5 years          3.5 years          3.5 years
      Expected volatility of underlying stock             69%                71%                69%                78%
      Expected dividend rate                             None               None               None               None


      In December 2004, the Financial Accounting Standards Board ("FASB") 
      issued Statement of Financial Accounting Standards No. 123R, Share-
      Based Payment ("SFAS No. 123R"). This Statement is a revision of SFAS 
      No. 123, and supersedes APB No. 25, and its related implementation 
      guidance.  SFAS No. 123R focuses primarily on accounting for 
      transactions in which an entity obtains employee services in share-
      based payment transactions. The Statement requires entities to 
      recognize stock compensation expense for awards of equity instruments 
      to employees based on the grant-date fair value of those awards (with 
      limited exceptions). SFAS No. 123R is effective for the Company's 
      annual reporting period that begins after June 15, 2005.

      The Company expects to adopt SFAS No. 123R using the Statement's 
      modified prospective application method.

      Adoption of SFAS No. 123R is expected to increase stock compensation 
      expense.  The Company is evaluating the effect that SFAS 123R will 
      have in subsequent years.  In addition, SFAS No. 123R requires that 
      the excess tax benefits related to stock compensation be reported as 
      a financing cash inflow rather than as a reduction of taxes paid in 
      cash from operations.

      The following is a summary of activity for all of the Company's stock 
      option plans:




                                                     Three Months Ended March 31, 2005     Nine Months Ended March 31, 2005

                                                                         Weighted-                            Weighted-
                                                         Shares           Average             Shares           Average
                                                          Under          Exercise              Under          Exercise
                                                         Option            Price              Option            Price

                                                                                                   
      Outstanding options at beginning of period         677,775          $11.29              567,775          $12.54
        Granted                                            2,000            6.69              132,500            5.99
        Cancelled                                          5,000           14.37               25,500           12.54
      Exercised                                                -               -                    -               -
                                                         -------          ------              -------          ------
      Outstanding options at end of period               674,775          $11.25              674,775          $11.25
                                                         =======          ======              =======          ======
      Exercisable options at end of period               400,442          $13.37              400,442          $13.37
                                                         =======          ======              =======          ======
      Weighted average fair value of options
       granted during the period                                          $ 3.31                               $2.98
                                                                          ======                               =====



  8


      The following table presents weighted-average price and life 
      information about significant option groups outstanding and 
      exercisable at March 31, 2005:




                                     Options Outstanding                    Options Exercisable
                          ------------------------------------------     -------------------------
                                           Weighted-
                                            Average        Weighted-                     Weighted-
                                           Remaining        Average        Number         Average
         Exercise           Number        Contractual      Exercise       of Shares      Exercise
          Prices          Outstanding     Life (Years)       Price       Exercisable       Price

                                                                           
      $ 0.00 - $5.95         13,500           4.3           $ 5.55          7,500         $ 5.67
        5.96 - 7.00         131,000           9.1             6.04          4,500           6.67
        7.01 - 9.00          88,000           8.4             8.39         26,500           8.39
        9.01 - 11.00         47,000           6.8            10.26         30,500          10.26
       11.01 - 12.00         81,900           7.3            11.51         40,950          11.51
       12.01 - 12.25         52,500           6.0            12.06         52,500          12.06
       12.26 - 13.00        105,500           5.6            12.48         82,617          12.47
       13.01 - 16.00         35,125           3.5            13.93         35,125          13.93
       16.01 - 18.00         55,750           4.4            16.25         55,750          16.25
       18.01 - 22.00         64,500           2.6            18.88         64,500          18.88
                            -------           ---           ------        -------         ------
      $ 0.00 - $22.00       674,775           6.4           $11.25        400,442         $13.37
                            =======           ===           ======        =======         ======


3.    Inventories
      -----------

      Inventories of raw materials are stated at the lower of cost (first-
      in, first-out) or market.  Work in process and finished goods are 
      valued as a percentage of completed cost, not in excess of net 
      realizable value.  Raw material, work in process and finished goods 
      inventory associated with programs cancelled by customers are fully 
      reserved for as obsolete.  Reductions in obsolescence reserves are 
      recognized when the underlying products are disposed of or sold.  
      Inventories consisted of:




                                    March 31,       June 30,
                                      2005            2004

                                             
      Raw materials                $10,725,952     $ 8,729,132
      Work in process               10,591,265       9,444,722
      Finished goods                 4,792,416       5,049,796
                                   -----------     -----------
      Total cost                    26,109,633      23,223,650
      Reserve for obsolescence      (2,926,688)     (2,897,516)
                                   -----------     -----------
      Inventory, net               $23,182,945     $20,326,134
                                   ===========     ===========



  9


4.    Property, Plant and Equipment
      -----------------------------

      Property, plant and equipment are stated at cost and are depreciated 
      using the straight-line method over their estimated useful lives.  
      Property, plant and equipment consisted of:




                                              March 31,         June 30,
                                                 2005             2004

                                                        
      Land and land improvements             $    589,872     $    589,872
      Buildings                                18,543,295       18,543,295
      Machinery and equipment                  64,259,307       64,348,226
      Leasehold improvements and other          6,967,567        6,695,173
      Construction in progress                  3,979,662        2,902,141
                                             ------------     ------------

      Total cost                               94,339,703       93,078,707
      Less: accumulated depreciation          (51,657,792)     (48,098,967)
                                             ------------     ------------
      Property, plant and equipment, net     $ 42,681,911     $ 44,979,740
                                             ============     ============


5.    Intangible Assets
      -----------------

      Intangible assets consisted of: 




                                   March 31,     June 30,
                                     2005          2004

                                           
      Patents                      $ 58,560      $ 58,560
      Accumulated amortization      (28,010)      (25,814)
                                   --------      --------
      Intangible assets, net       $ 30,550      $ 32,746
                                   ========      ========


      The Company has reassessed the remaining useful lives of the 
      intangible assets at March 31, 2005 and determined the useful lives 
      are appropriate in determining amortization expense.  Amortization 
      expense for the nine months ended March 31, 2005 and March 28, 2004 
      was $2,196 and $3,913, respectively.


  10


6.    Other Assets
      ------------

      Other assets consisted of: 




                                                                                      March 31,       June 30,
                                                                                         2005           2004

                                                                                               
      Deferred loss on sale-leaseback of Poly-Flex Facility, net                      $  881,533     $1,087,606
      Deferred financing costs on sale-leaseback of Methuen facility (see Note 7)        363,575        361,700
      Deferred financing costs on the Loan and Security Agreement (see Note 7)           335,402        267,722
      Deferred financing costs on Convertible Subordinated Note (see Note 7)             673,930        673,930
      Other                                                                               56,968        160,650
                                                                                      ----------     ----------
      Total cost                                                                       2,311,408      2,551,608
      Less: accumulated amortization                                                    (529,520)      (268,472)
                                                                                      ----------     ----------
      Total Other Assets, net                                                         $1,781,888     $2,283,136
                                                                                      ==========     ==========


      In 2003, Poly-Flex sold its operating facility in Cranston, Rhode 
      Island and entered into a five-year lease of the Poly-Flex Facility 
      with the buyer.  The Company did not record an immediate loss on the 
      transaction since the fair value of the Poly-Flex Facility exceeded 
      the net book value of the facility at the time of sale.  However, 
      approximately $1,374,000 of excess net book value over the sales 
      price was recorded as a deferred loss and included in Other Assets - 
      Net on the condensed consolidated balance sheets.  The deferred loss 
      is being amortized to lease expense over the five-year lease term.  
      Amortization of the deferred loss, reported as a component of rent 
      expense, was $206,000 for the nine months ended March 31, 2005 and 
      March 28, 2004.

      Amortization of deferred financing costs was $261,000 and $196,000 
      for the nine months ended March 31, 2005 and March 28, 2004, 
      respectively.

7.    Accrued Liabilities - Facility Exit Costs
      -----------------------------------------

      The following is a summary of the facility exit costs activity during 
      the nine months ended March 31, 2005:




                                               Facility                               Facility
                                              Exit Costs       FY2005 Activity       Exit Costs
                                                Accrued             Cash              Accrued
                                             June 30, 2004        Payments         March 31, 2005
                                             -------------     ---------------     --------------

                                                                             
      Total facility refurbishment costs       $136,952           $(7,962)            $128,990


      The remaining accrued facility exit costs at March 31, 2005 represent 
      the estimated costs to refurbish the facility.  The Company expects 
      the balance of accrued facility exit costs at March 31, 2005 to be 
      paid by the end of fiscal 2005.


  11


8.    Long-term Debt
      --------------

      Long-term debt consisted of:




                                                                    March 31,       June 30,
                                                                      2005            2004

                                                                             
      Loan and Security Agreement                                  $ 3,951,182     $ 3,618,091
      Parlex Shanghai term notes                                     7,662,569       8,870,792
      Parlex Interconnect term note                                    604,120               -
      Parlex Asia banking facility                                   1,750,829               -
      Finance obligation on sale-leaseback of Methuen Facility       8,400,820       5,909,245
      Convertible Subordinated Note                                  4,792,482       4,404,351
      Other                                                            645,797         593,277
                                                                   -----------     -----------
      Total long-term debt                                          27,807,799      23,395,756
      Less: current portion of long-term debt                       14,341,766      12,861,077
                                                                   -----------     -----------
      Long-term debt                                               $13,466,033     $10,534,679
                                                                   ===========     ===========


      A summary of the current portion of our long-term debt described 
      above is as follows:




                                                                    March 31,       June 30,
                                                                      2005            2004

                                                                             
      Loan and Security Agreement                                  $ 3,951,182     $ 3,618,091
      Parlex Shanghai term notes                                     7,662,569       8,870,792
      Parlex Interconnect term note                                    604,120               -
      Parlex Asia banking facility                                   1,750,829               -
      Finance obligation on sale-leaseback of Methuen Facility         136,960         263,849
      Other                                                            236,106         108,345
                                                                   -----------     -----------

      Total current portion of long-term debt                      $14,341,766     $12,861,077
                                                                   ===========     ===========


      Loan and Security Agreement ("the Loan Agreement") - The Company 
      executed the Loan Agreement with Silicon Valley Bank on June 11, 
      2003, and since such date has entered into eight amendments to the 
      Loan Agreement. The Loan Agreement provided Silicon Valley Bank with 
      a secured interest in substantially all of the Company's assets. The 
      Company may borrow up to $12.0 million based on a borrowing base of 
      eligible accounts receivable. Borrowings may be used for working 
      capital purposes only. The Loan Agreement allows the Company to 
      issue letters of credit, enter into foreign exchange forward 
      contracts and incur obligations using the bank's cash management 
      services up to an aggregate limit of $1.0 million, which reduces the 
      Company's availability for borrowings under the Loan Agreement.  As 
      of March 31, 2005, the Company had a $1.0 million letter of credit 
      outstanding.  The Loan Agreement contains certain restrictive 
      covenants, including but not limited to, limitations on debt incurred 
      by its foreign subsidiaries, acquisitions, sales and transfers of 
      assets, and prohibitions against cash dividends, mergers and 
      repurchases of stock without prior bank approval.  The Loan Agreement 
      also has financial covenants, which among other things require the 
      Company to maintain $750,000 in minimum cash balances or excess 
      availability under the Loan Agreement.

      On December 22, 2004, the Company executed a Seventh Loan 
      Modification Agreement (the "Seventh Modification Agreement") with 
      Silicon Valley Bank.  The Seventh Modification Agreement increased 
      the Company's maximum borrowings to $12.0 million based upon a 
      borrowing base of eligible accounts


  12


      receivable plus the lesser of 20% of eligible inventory or $1.0 
      million.  The Seventh Modification Agreement reduced the interest 
      rate on borrowings to the bank's prime rate (5.75% at March 31, 2005) 
      plus 2.00% (decreasing to prime plus 1.25% after two consecutive 
      quarters of positive operating income and to prime plus 0.50% after 
      two consecutive quarters of positive net income, respectively).  The 
      Seventh Modification Agreement changed the EBITDA requirement to 
      $500,000 on a three month trailing basis as of the period ending 
      December 31, 2004 and each month thereafter until May 31, 2005 and to 
      $750,000 on a three month trailing basis as of the period ending June 
      30, 2005 and each month thereafter.  The Seventh Modification 
      Agreement also extended the maturity date of the Loan Agreement from 
      July 11, 2005 to July 11, 2006.  On May 10, 2005, the Company 
      executed an Eighth Loan Modification Agreement (the "Eighth 
      Modification Agreement") with Silicon Valley Bank.  The Eighth 
      Modification Agreement changed the EBITDA requirement to $1.00 on a 
      monthly basis as of the period ending April 30, 2005 and May 31, 2005 
      and $750,000 on a trailing three month basis as of the period ending 
      June 30, 2005 and each month thereafter.  As of March 31, 2005, the 
      Company was not in compliance with certain Loan Agreement financial 
      covenants.  The Company has received a waiver from bank of its non-
      compliance at March 31, 2005, and the bank has continued to allow the 
      Company to borrow against the Loan Agreement.  At March 31, 2005, the 
      Company had available borrowing capacity under the Loan Agreement of 
      approximately $4.8 million.  As the available borrowing capacity 
      exceeded $750,000 at March 31, 2005, none of the Company's cash 
      balance was subject to restriction at March 31, 2005.

      The Loan Agreement includes both a subjective acceleration clause and 
      a lockbox arrangement that requires all lockbox receipts to be used 
      to pay down the revolving credit borrowings.  Accordingly, borrowings 
      under the Loan Agreement are classified as current liabilities in the 
      accompanying consolidated balance sheets as of March 31, 2005 and 
      June 30, 2004 as required by Emerging Issues Task Force Issue No. 95-
      22, "Balance Sheet Classification of Borrowings Outstanding Under 
      Revolving Credit Agreements that include both a Subjective 
      Acceleration Clause and a Lockbox Arrangement".  However, such 
      borrowings will be excluded from current liabilities in future 
      periods and considered long-term obligations if: 1) such borrowings 
      are refinanced on a long-term basis, 2) the subjective acceleration 
      terms of the Loan Agreement are modified, or 3) such borrowings will 
      not require the use of working capital within one year.

      Parlex Shanghai Term Notes - A summary of the Parlex Shanghai term 
      notes are as follows:




                                                                            March 31, 2005
                                                                            (in millions)

                                                                              
      Due March 2006 at 5.58% and guaranteed by Parlex Interconnect              $2.5
      Due January 2006 at LIBOR plus 2.5% and guaranteed by Parlex Asia           1.5
      Due June 2005 at 5.58% and guaranteed by Parlex Interconnect                1.3
      Due June 2005 at 5.58% and guaranteed by Parlex Interconnect                1.0
      Due April 2005 at 5.31% and guaranteed by Parlex Interconnect               0.7
      Due March 2006 at 5.58% and guaranteed by Parlex Interconnect               0.6
                                                                                 ----
      Total Parlex Shanghai term notes                                           $7.6
                                                                                 ====


      Subsequent to March 31, 2005, Parlex Shanghai renewed its $700,000 
      short-term note due April 2005.  The note has been extended until 
      April 2006 at an interest rate of 5.58%.

      Parlex Interconnect Term Note - On October 28, 2004, Parlex 
      Interconnect entered into a $605,000 short-term bank note, due October 
      27, 2005, bearing interest at 5.31% and guaranteed by Parlex Shanghai.


  13


      Parlex Asia Banking Facility - On September 15, 2004, Parlex Asia 
      entered into an agreement with the Bank of China for a $5 million 
      banking facility guaranteed by Parlex. Under the terms of the banking 
      facility, Parlex Asia may borrow up to $5 million based on a 
      borrowing base of eligible account receivables. The banking facility 
      bears interest at LIBOR plus 2.00%.  Amounts outstanding as of March 
      31, 2005 totaled $1.8 million.

      Finance Obligation on Sale Leaseback of Methuen Facility - In June 
      2003, Parlex entered into a sale-leaseback transaction pursuant to 
      which it sold its corporate headquarters and manufacturing facility 
      located in Methuen, Massachusetts (the "Methuen Facility") for a 
      purchase price of $9.0 million.  The purchase price consisted of 
      $5.35 million in cash at the closing, a promissory note in the amount 
      of $2.65 million (the "Note") and up to $1.0 million in additional 
      cash under the terms of an Earn Out Clause (the "Earn Out").  In June 
      2004, Parlex received $750,000 reducing the principal balance of the 
      Note to $1.9 million.  On February 25, 2005, the landlord sold the 
      Methuen Facility and paid the Company the remaining principal balance 
      due on the Note of $1.9 million and agreed to pay the sum of $675,000 
      in full settlement of the Earn Out.  Per the terms of the sale of the 
      Methuen Facility, $400,000 of the $675,000 was placed in escrow as 
      security for the Company's remaining lease obligations.

      As the repurchase option contained in the lease and the receipt of 
      the Note from the buyer provide Parlex with a continuing involvement 
      in the Methuen Facility, Parlex has accounted for the sale-leaseback 
      of the Methuen Facility as a financing transaction. Accordingly, the 
      Company continues to report the Methuen Facility as an asset and 
      continues to record depreciation expense.  The Company records all 
      cash received under the transaction as a finance obligation.  The 
      Note and related interest thereon, and the additional cash under the 
      terms of the Earn Out, were recorded as an increase to the finance 
      obligation as cash payments were received.  The Company records the 
      principal portion of the monthly lease payments as a reduction to the 
      finance obligation and the interest portion of the monthly lease 
      payments is recorded as interest expense.  The closing costs for the 
      transaction have been capitalized and are being amortized as interest 
      expense over the initial 15-year lease term.  Upon expiration of the 
      repurchase option in June 2015, the Company will reevaluate its 
      accounting to determine whether a gain or loss should be recorded on 
      this sale-leaseback transaction. 

      Convertible Subordinated Notes - On July 28, 2003, Parlex sold an 
      aggregate $6.0 million of its 7% convertible subordinated notes (the 
      "Notes") with attached warrants to several institutional investors. 
      The Company received net proceeds of approximately $5.5 million from 
      the transaction, after deducting approximately $500,000 in finders' 
      fees and other transaction expenses. Net proceeds were used to pay 
      down amounts borrowed under the Company's Loan Agreement and utilized 
      for working capital needs. No principal payments are due until 
      maturity on July 28, 2007. The Notes are unsecured.

      The Notes bear interest at a fixed rate of 7%, payable quarterly in 
      shares of Parlex common stock. The number of shares of common stock 
      to be issued is calculated by dividing the accrued quarterly interest 
      by a conversion price, which was initially established at $8.00 per 
      share.  The conversion price is subject to adjustment in the event of 
      stock splits, dividends and certain combinations.

      Interest expense is recorded quarterly based on the fair value of the 
      common shares issued. Accordingly, interest expense may fluctuate 
      from quarter to quarter. The Company has concluded that the interest 
      feature does not constitute an embedded derivative as it does not 
      currently meet the criteria for classification as a derivative.

      The Company recorded accrued interest payable on the Notes of $83,331 
      within stockholders' equity at March 31, 2005, as the interest is 
      required to be paid quarterly in the form of common stock.  Based on 
      the conversion price of $8.00 per common share, the Company issued a 
      total of 74,963 shares of common stock from October 2003 to January 
      2005 in satisfaction of previously recorded interest and issued 
      13,123 shares of common stock in April 2005 as payment for the 
      interest accrued at March 31, 2005.


  14


      The Notes contain a beneficial conversion feature reflecting an 
      effective initial conversion price that was less than the fair market 
      value of the underlying common stock on July 28, 2003.  The fair 
      value of the beneficial conversion feature was approximately $1.035 
      million, which has been recorded as an increase to additional paid-in 
      capital and as an original issue discount on the Notes that is being 
      amortized to interest expense over the four year life of the Notes.

      After two years from the date of issuance, the Company has the right 
      to redeem all, but not less than all, of the Notes at 100% of the 
      remaining principal of Notes then outstanding, plus all accrued and 
      unpaid interest, under certain conditions.  After three years from 
      the date of issuance, the holder of any of the Notes may require the 
      Company to redeem the Notes in whole, but not in part.  Such 
      redemption shall be at 100% of the remaining principal of such Notes, 
      plus all accrued and unpaid interest.  In the event of a Change in 
      Control (as defined therein), the holder has the option to require 
      that the Notes be redeemed in whole (but not in part), at 120% of the 
      outstanding unpaid principal amount, plus all unpaid accrued 
      interest.

9.    Stockholders' Equity
      --------------------

      Series A Convertible Preferred Stock - On May 7, 2004 and June 8, 
      2004, the Company completed a private placement of 40,625 shares of 
      Series A Convertible Preferred Stock (the "Series A Preferred Stock") 
      and warrants at $80.00 per unit for proceeds of approximately $2.95 
      million, net of issuance costs of approximately $300,000.  In 
      connection with the private placement, investors received rights to 
      purchase additional shares of the Series A Preferred Stock (the 
      "Over-Allotment Right").  The warrants are exercisable immediately 
      and entitle holders to purchase 203,125 shares of common stock at an 
      exercise price of $8.00 per share (subject to adjustment for certain 
      dilutive events) and expire on May 7, 2007 and June 8, 2007.  

      The Series A Preferred Stock is redeemable at the Company's option on 
      the third anniversary of the closing, upon 30 days notice to the 
      holders, in whole but not in part, at $80.00 per share (subject to 
      adjustment for certain dilutive events) together with all accrued but 
      unpaid dividends to the redemption date.  The Series A Preferred 
      Stockholders have no voting rights, except with respect to certain 
      limited matters that directly impact the Series A Preferred Stock. 

      Each share of Series A Preferred Stock is only convertible into 10 
      shares of common stock at the option of the holder at any time, until 
      20 days following the date on which the Company first mails its 
      notice of redemption, if any.  The initial conversion price of $8.00 
      is adjusted for certain dilutive events.  The Series A Preferred 
      Stock is subject to mandatory conversion if the Company's common 
      stock price closes above $12.00 per share for twenty (20) consecutive 
      trading days. 

      The Series A Preferred Stock is entitled to receive cumulative 
      dividends at an annual rate of 8.25% ($6.60 per share), payable 
      quarterly in cash or shares of common stock or a combination of cash 
      and stock at the election of the Company.  In the event the Company 
      does not exercise its right to redeem the Series A Preferred Stock on 
      the third anniversary, the dividend rate shall increase to 14% 
      ($11.20 per share) per annum payable quarterly exclusively in cash.

      The Preferred Stock also entitles the holders thereof to a 
      preferential payment in the event of the Company's voluntary or 
      involuntary liquidation, dissolution or winding up.  Specifically, in 
      any such case, the holders of Preferred Stock shall be entitled to be 
      paid, out of the Company's assets that are available for distribution 
      to our shareholders, the sum of $80.00 per share of Preferred Stock 
      held, or $3.25 million, plus all accrued and unpaid dividends 
      thereon, prior to any payments being made to holders of our common 
      stock.  The $80.00 per share liquidation preference payment amount is 
      subject to equitable adjustment for stock splits, stock dividends, 
      combinations, reorganizations and similar events effecting the shares 
      of Preferred Stock.


  15


      The Over-Allotment Right, which has now expired, allowed each 
      investor to purchase additional shares of Series A Preferred Stock in 
      an amount up to 20% of the original purchase and on the same terms as 
      the original purchase.

      As the original price of $80.00 included a share of Series A 
      Preferred Stock, a warrant to purchase five shares of common stock 
      and the Over-Allotment Right, the Company used the relative fair 
      value method to record the transaction.  Accordingly, $2.668 million, 
      $486,000 and $96,000 of the gross proceeds were attributed to the 
      40,625 shares of Series A Preferred Stock, the 203,125 common stock 
      warrants and the Over-Allotment Right, respectively. Since 38,750 
      shares of Series A Preferred Stock were issued for an effective 
      purchase price of $6.56 per share, which was lower than the fair 
      market value of the common stock at the date of closing, the 
      investors realized a beneficial conversion feature of approximately 
      $131,750.  Accordingly, the beneficial conversion feature and the 
      relative fair value of the warrants and Over-Allotment Right have 
      been recorded as an increase to additional paid-in capital.  The 
      beneficial conversion feature was immediately accreted. 

      Common Stock Warrants - The Company has issued common stock warrants 
      in connection with certain financings.  All warrants are currently 
      exercisable and the following table summarizes information about 
      common stock warrants outstanding to lenders and investors at March 
      31, 2005: 




      Fiscal Year       Number        Weighted-Average      Expiration
        Granted       Outstanding      Exercise Price          Date
      -----------     -----------     ----------------      ----------

                                                  
         2003            25,000            $6.89           June 10, 2008
         2004           225,000             8.00           July 28, 2007
         2004            31,500             8.00           July 28, 2008
         2004           193,750             8.00           May 7, 2007
         2004             9,375             8.00           June 8, 2007
                        -------            -----
         Total          484,625            $7.94
                        =======            =====


      Upon execution of the Loan Agreement on June 10, 2003, the Company 
      issued warrants for the purchase of 25,000 shares of its common stock 
      to Silicon Valley Bank at an initial exercise price of $6.89 per 
      share.  The exercise price is subject to future adjustment under 
      certain conditions, including but not limited to, stock splits and 
      stock dividends.  The fair value of the warrants on June 10, 2003 was 
      approximately $100,600, which was recorded as a deferred financing 
      cost and is being amortized to interest expense over the life of the 
      Loan Agreement.  Amortization expense for the nine months ended March 
      31, 2005 and March 28, 2004 was $38,000.

      In connection with the sale of the Convertible Subordinated Notes, 
      the investors and the investment adviser received warrants to 
      purchase 331,500 shares of common stock, at an initial exercise price 
      of $8.00 per share.  The exercise price of the warrants is subject to 
      adjustment in the event of stock splits, dividends and certain 
      combinations.  The relative fair value of the warrants issued to the 
      investors and to the investment adviser on July 28, 2003 was 
      approximately $1.0 million and $146,000, respectively.  The relative 
      fair value of the warrants was recorded as an increase in additional 
      paid-in capital and as an original issuance discount recorded against 
      the carrying value of the Notes.  In December 2003, one of the 
      investors exercised their warrants to purchase 75,000 shares of the 
      Company's common stock and the Company received proceeds of $600,000.  
      The original issue discount is being amortized to interest expense 
      over the four year life of the Note and totaled $216,900 for the nine 
      months ended March 31, 2005.

      In connection with the sale of the Series A Convertible Preferred 
      Stock, the investors received common stock purchase warrants for an 
      aggregate of 203,125 shares of common stock at an initial exercise 
      price of $8.00


  16


      per share.  The conversion price of the Preferred Stock and the 
      exercise price of the Warrants are subject to adjustment in the event 
      of stock splits, dividends and certain combinations.

      Treasury Stock - Effective July 1, 2004, companies incorporated in 
      Massachusetts became subject to the Massachusetts Business 
      Corporation Act, Chapter 156D.  The new Act eliminates the concept of 
      "treasury stock" and instead Section 6.31 of Chapter 156D provides 
      that shares that are reacquired by a company become authorized but 
      unissued shares.  Accordingly, shares previously reported as treasury 
      stock by the Company have been redesignated, at an aggregate cost of 
      approximately $1.0 million, as authorized but unissued shares.  This 
      aggregate cost has been allocated to the common stock's par value and 
      additional paid-in capital.

10.   Revenue Recognition
      -------------------

      Revenue on product sales is recognized when persuasive evidence of an 
      agreement exists, the price is fixed or determinable, delivery has 
      occurred and there is reasonable assurance of collection of the sales 
      proceeds.  The Company generally obtains written purchase 
      authorizations from its customers for a specified amount of product, 
      at a specified price and considers delivery to have occurred at the 
      time title to the product passes to the customer.  Title passes to 
      the customer according to the shipping terms negotiated between the 
      Company and the customer.  License fees and royalty income are 
      recognized when earned.

11.   Income Taxes
      ------------

      Income taxes are recorded for interim periods based upon an estimated 
      annual effective tax rate.  The Company's effective tax rate is 
      impacted by the proportion of its estimated annual income being 
      earned in domestic versus foreign tax jurisdictions, the generation 
      of tax credits and the recording of a valuation allowance.

      The Company performs an ongoing evaluation of the realizability of 
      its net deferred tax assets.  As a result of its operating losses, 
      uncertain future operating results, and past non-compliance with 
      certain of its debt covenant requirements, the Company determined 
      during fiscal 2003 that it is more likely than not that certain 
      historic and current year income tax benefits will not be realized.  
      Consequently, the Company established a valuation allowance against 
      all of its U.S. net deferred tax assets and has not given recognition 
      to these net tax assets in the accompanying financial statements at 
      March 31, 2005.  Upon a favorable change in the operations and 
      financial condition of the Company that results in a determination 
      that it is more likely than not that all or a portion of the net 
      deferred tax assets will be utilized, all or a portion of the 
      valuation allowance previously provided for will be eliminated.

12.   Net Loss Per Share
      ------------------

      Basic net loss per share is calculated on the weighted-average number 
      of common shares outstanding during the period. Diluted net loss per 
      share is calculated on the weighted-average number of common shares 
      and common share equivalents resulting from outstanding options and 
      warrants except where such items would be antidilutive.


  17


      The net loss attributable to common stockholders for each period is 
      as follows: 




                                                               Three Months Ended                     Nine Months Ended
                                                        March 31, 2005     March 28, 2004     March 31, 2005     March 28, 2004
                                                        --------------     --------------     --------------     --------------

                                                                                                      
      Net loss                                           $(2,275,674)       $(2,590,076)       $(4,522,086)       $(6,604,341)
      Dividends accrued on Series A preferred stock          (66,113)                 -           (201,279)                 -
                                                         -----------        -----------        -----------        -----------
      Net loss attributable to common stockholders       $(2,341,787)       $(2,590,076)       $(4,723,365)       $(6,604,341)
                                                         ===========        ===========        ===========        ===========


      Antidilutive shares were not included in the per-share calculations 
      for the three and nine months ended March 31, 2005 and March 28, 2004 
      due to the reported net losses for those periods.  Antidilutive 
      shares totaled approximately 1.2 million and 844,000 for the nine 
      months ended March 31, 2005 and March 28, 2004, respectively.  All 
      antidilutive shares relate to outstanding stock options except for 
      484,625 and 272,500 antidilutive shares for the nine months ended 
      March 31, 2005 and March 28, 2004, respectively relating to warrants 
      issued in connection with certain debt and equity financings (see 
      Note 9).

13.   Comprehensive Loss
      ------------------

      Comprehensive loss for the three and nine months ended March 31, 2005 
      and March 28, 2004 is as follows:




                                                            Three Months Ended                     Nine Months Ended
                                                     March 31, 2005     March 28, 2004     March 31, 2005     March 28, 2004
                                                     --------------     --------------     --------------     --------------

                                                                                                   
      Net loss                                        $(2,275,674)       $(2,590,076)       $(4,522,086)       $(6,604,341)
      Other comprehensive income (loss):
        Foreign currency translation adjustments          (93,357)           197,048            271,916            340,959
                                                      -----------        -----------        -----------        -----------

      Total comprehensive loss                        $(2,369,031)       $(2,393,028)       $(4,250,170)       $(6,263,382)
                                                      ===========        ===========        ===========        ===========


      At March 31, 2005 and June 30, 2004, the Company's accumulated other 
      comprehensive loss pertains entirely to foreign currency translation 
      adjustments.

14.   Joint Venture
      -------------

      On December 22, 2004, Parlex entered into a Joint Venture Agreement 
      (amended March 28, 2005), Stock Transfer Agreement and License 
      Agreement (collectively, the "Agreements") with Infineon Technologies 
      Asia Pacific Pte. Ltd ("Infineon"), a wholly-owned subsidiary of 
      Infineon Technologies AG.  Pursuant to the Agreements, Infineon will 
      purchase, for an aggregate $3.0 million, a 49% interest in a new 
      entity to be formed by Parlex. Under the terms of the Agreements, the 
      Company is required to obtain certain governmental approvals from the 
      People's Republic of China with respect to establishing the new 
      entity, and be able to consummate the transaction no later than July 
      1, 2005 (the "Outside Closing Date").

      Upon execution of the Agreements, the Company received a deposit of 
      an aggregate $1.0 million of the total purchase price.  Specifically, 
      Infineon paid $500,000 to the Company as consideration for the 
      License Agreement, pursuant to which the Company granted Infineon a 
      license relating to certain proprietary technology used in connection 
      with the business to be operated by the joint venture.  Infineon also 
      paid $500,000 of the $2.5 million to be payable to the Company under 
      the Stock Transfer Agreement, with the remaining $2.0 million to be 
      paid at closing.  In the event the transaction is not consummated on 
      or before the Outside Closing Date, the Company is required to repay 
      the $1.0 million, or Infineon shall be entitled to offset such amount 
      against certain Company invoices submitted to Infineon.


  18

15.   Other Recent Accounting Pronouncements
      --------------------------------------

      In November 2004, the FASB issued Statement No. 151, Inventory Costs, 
      an amendment to ARB No. 43, Chapter 4. Statement 151 clarifies the 
      accounting for abnormal amounts of idle facility expense, freight, 
      handling costs and wasted material.  Statement 151 is effective for 
      inventory costs incurred during fiscal years beginning after June 15, 
      2005.  The Company is presently evaluating the effect that adoption 
      of Statement 151 will have on its consolidated financial position, 
      results of operations or cash flows.

      In December 2004, the FASB issued Statement No. 153, Exchanges of 
      Nonmonetary Assets, an amendment of APB Opinion No. 29. Statement 153 
      addresses the measurement of exchanges of nonmonetary assets and 
      redefines the scope of transactions that should be measured based on 
      the fair value of the assets exchanged. Statement 153 is effective 
      for nonmonetary asset exchanges occurring in fiscal periods beginning 
      after June 15, 2005. The Company does not believe that adoption of 
      Statement 153 will have a material effect on its consolidated 
      financial position, results of operations or cash flows. 

      In December 2004, the FASB issued FASB Staff Position No. 109-1,  
      Application of FASB  Statement  No. 109 (SFAS 109),  Accounting  for 
      Income Taxes, to the Tax Deduction  on Qualified  Production  
      Activities  Provided by the  American  Jobs Creation Act of 2004 (FSP 
      109-1).  FSP 109-1 clarifies that the manufacturer's deduction 
      provided for under the American Jobs Creation Act of 2004 (AJCA) 
      should be accounted for as a special deduction in accordance with 
      SFAS 109 and not as a tax rate reduction.  The adoption of FSP 109-1 
      will have no impact on the Company's results of operations or 
      financial position for fiscal year 2005 because the manufacturer's 
      deduction is not available to the Company until fiscal year 2006.  
      The Company is presently evaluating the effect that the 
      manufacturer's deduction will have in subsequent years.

      The FASB also issued FASB Staff Position No. 109-2, Accounting and 
      Disclosure Guidance for the Foreign Earnings Repatriation Provision 
      within the American Jobs Creation Act of 2004 (FSP 109-2).  The AJCA 
      introduces a special one-time dividends received deduction on the 
      repatriation of certain foreign earnings to a U.S. taxpayer 
      (repatriation provision), provided certain criteria are met.  FSP 
      109-2 provides accounting and disclosure guidance for the 
      repatriation provision.  Until the Treasury Department or Congress 
      provides additional clarifying language on key elements of the 
      repatriation provision, the amount of foreign earnings to be 
      repatriated by the Company, if any, cannot be determined and the 
      presumption that such unremitted earnings will be repatriated cannot 
      be overcome.  FSP 109-2 grants an enterprise additional time beyond 
      the year ended March 31, 2005, in which the AJCA was enacted, to 
      evaluate the effects of the AJCA on its plan for reinvestment or 
      repatriation of unremitted earnings.  FSP 109-2 calls for enhanced 
      disclosures of, among other items, the status of a Company's 
      evaluations, the effects of completed evaluations, and the potential 
      range of income tax effects of repatriations. 


  19


Item 2.  Management's Discussion and Analysis of Financial Condition and
------------------------------------------------------------------------
Results of Operations
---------------------

This Management's Discussion and Analysis of Financial Condition and 
Results of Operations should be read in conjunction with the financial 
information included in this Quarterly Report on Form 10-Q and with 
"Factors That May Affect Future Results" set forth on page 31.  The 
following discussion contains forward-looking statements within the meaning 
of the Private Securities Litigation Reform Act of 1995, and is subject to 
the safe-harbor created by such Act. Forward-looking statements express our 
expectations or predictions of future events or results.  They are not 
guarantees and are subject to many risks and uncertainties.  There are a 
number of factors - many beyond our control - that could cause actual 
events or results to be significantly different from those described in the 
forward-looking statement.  Any or all of our forward-looking statements in 
this report or in any other public statements we make may turn out to be 
wrong. Forward-looking statements can be identified by the fact that they 
do not relate strictly to historical or current facts.  They use words such 
as "anticipate," "estimate," "expect," "project," "intend," "plan," 
"believe" or words of similar meaning.  They may also use words such as 
"will," "would," "should," "could" or "may".  Our actual results could 
differ materially from the results contemplated by these forward-looking 
statements as a result of many factors, including those discussed below and 
elsewhere in this Quarterly Report on Form 10-Q.

Our significant accounting policies are more fully described in Note 3 to 
our consolidated financial statements in our Annual Report on Form 10-K for 
the year ended June 30, 2004.  However, certain of our accounting policies 
are particularly important to the portrayal of our financial position and 
results of operations and require the application of significant judgment 
by our management which subjects them to an inherent degree of uncertainty.  
In applying our accounting policies, our management uses its best judgment 
to determine the appropriate assumptions to be used in the determination of 
certain estimates. Those estimates are based on our historical experience, 
terms of existing contracts, our observance of trends in the industry, 
information provided by our customers, information available from other 
outside sources, and on various other factors that we believe to be 
appropriate under the circumstances. We believe that the critical 
accounting policies discussed below involve more complex management 
judgment due to the sensitivity of the methods, assumptions and estimates 
necessary in determining the related asset, liability, revenue and expense 
amounts.

Overview

We believe we are a leading supplier of flexible interconnects principally 
for sale to the automotive, telecommunications and networking, diversified 
electronics, military, home appliance, electronic identification, medical and 
computer markets.  We believe that our development of innovative materials 
and processes provides us with a competitive advantage in the markets in 
which we compete.  During the past three fiscal years, we have invested 
approximately $12.4 million in property and equipment and approximately $17.7 
million in research and development to develop materials and enhance our 
manufacturing processes.  We believe that these expenditures will help us to 
meet customer demand for our products, and enable us to continue to be a 
technology leader in the flexible interconnect industry.  Our research and 
development expenses are included in our cost of products sold. 

Over the past three years, we were adversely affected by the economic 
downturn and its impact on our key customers and markets.  Beginning in 2004, 
we experienced sales growth in several strategic markets, particularly in the 
second half of the fiscal year.  Growth in the medical, home appliance and 
military markets has helped to reduce domestic losses. Significant investment 
over the past three years has positioned us to capitalize on a rapidly 
expanding China electronic manufacturing industry.  In 2004, our China 
operations revenues increased by over 65% with significant improvement in 
profitability. 

During fiscal years 2002, 2003 and 2004 we incurred aggregate operating 
losses of $35.3 million and used cash to fund operations and working capital 
of $13.7 million.  We have taken certain steps to improve operating margins, 
including the closure of facilities, downsizing of our North American 
employee base, and transfer of our manufacturing operations to lower cost 
locations, such as the People's Republic of China. In addition, we


  20


have worked closely with our lenders to manage through this difficult time 
and have obtained additional capital in 2003 and 2004 through sale-leasebacks 
of selected corporate assets, the issuance of convertible debt and preferred 
stock and the execution of new working capital borrowing agreements. As a 
result of the difficult economic environment, we have had difficulty 
maintaining compliance with the terms and conditions of certain of our 
financing facilities.  At March 31, 2005, we were not in compliance with 
certain financial covenants of our loan agreement with Silicon Valley Bank.  
We have received a written waiver from the bank, for our non-compliance at 
March 31, 2005, and the bank has continued to allow us to borrow against the 
loan agreement.  Our fiscal third quarter ending March 31 is typically 
adversely impacted by the cyclical nature of certain strategic markets we 
serve.  This is particularly true in the computer and peripheral market where 
annual model year design change occurs in January.  Coupled with the Chinese 
New Year holidays, the third quarter is historically the weakest for our 
rapidly growing China operations.  New production awards began ramping up in 
March 2005.  As such, we anticipate a strong recovery in volume production 
during the fourth quarter ending June 30, 2005.  In the future, we expect to 
be in compliance with all our bank covenants.

We have $5.4 million in existing short-term debt associated with our Chinese 
operations that will be refinanced or repaid in 2005.  We believe that we 
will be able to obtain the necessary refinancing of this debt because of our 
history of successfully refinancing our short-term Chinese borrowings and our 
Chinese operation's strong operating results.  In fiscal 2004, revenues from 
our Chinese operations grew 65%.  In the nine months ended March 31, 2005, 
revenues from our Chinese operations grew 56% compared to the nine months 
ended March 28, 2004.  We expect continued revenue growth and improved 
profitability in China during fiscal 2005.  The economy in China continues to 
expand rapidly, often outpacing local infrastructure development. During the 
past year the Chinese government has taken a series of steps to control 
economic growth. These steps include tightening of monetary policies 
particularly in industries such as building and commercial real estate 
development. Controls over credit have slowed bank loan growth. Additional 
short term lending may be more difficult to obtain in the future. Failure to 
obtain the necessary refinancing of our short-term Chinese debt may have a 
material adverse impact on our operations.

Critical Accounting Policies

The U.S. Securities and Exchange Commission defines critical accounting 
policies as those that are, in management's view, most important to the 
portrayal of the company's financial condition and results of operations 
and most demanding of their judgment.  We believe the following policies to 
be critical to an understanding of our consolidated financial statements 
and the uncertainties associated with the complex judgments made by us that 
could impact our results of operations, financial position and cash flows.  
Our significant accounting policies are more fully described in our Annual 
Report on Form 10-K for the year ended June 30, 2004.

The preparation of consolidated financial statements requires that we make 
estimates and judgments that affect the reported amounts of assets, 
liabilities, revenues and expenses, and related disclosures.  On an ongoing 
basis, we evaluate our estimates, including those related to bad debts, 
inventories, property, plant and equipment, goodwill and other intangible 
assets, valuation of stock options and warrants, income taxes and other 
accrued expenses, including self-insured health insurance claims.  We base 
our estimates on historical experience and on various other assumptions 
that are believed to be reasonable under the circumstances, the results of 
which form the basis for making judgments about the carrying values of 
assets and liabilities that are not readily apparent from other sources.  
In applying our accounting policies, our management uses its best judgment 
to determine the appropriate assumptions to be used in the determination of 
certain estimates.  Actual results would differ from these estimates.

Revenue recognition and accounts receivable. We recognize revenue on product 
sales when persuasive evidence of an agreement exists, the price is fixed and 
determinable, delivery has occurred and there is reasonable assurance of 
collection of the sales proceeds.  We generally obtain written purchase 
authorizations from our customers for a specified amount of product, at a 
specified price and consider delivery to have 


  21


occurred at the time title to the product passes to the customer. Title 
passes to the customer according to the shipping terms negotiated between the 
customer and us.  License fees and royalty income are recognized when earned.  
We have demonstrated the ability to make reasonable and reliable estimates of 
product returns in accordance with SFAS No. 48 and of allowances for doubtful 
accounts based on significant historical experience.  We maintain allowances 
for doubtful accounts for estimated losses resulting from the inability of 
our customers to make required payments.  If the financial condition of our 
customers were to deteriorate, resulting in an impairment of their ability to 
make payments, additional allowances may be required.

Inventories. We value our raw material inventory at the lower of the actual 
cost to purchase and/or manufacture the inventory or the current estimated 
market value of the inventory.  Work in process and finished goods are valued 
as a percentage of completed cost, not in excess of net realizable value. We 
regularly review our inventory and record a provision for excess or obsolete 
inventory based primarily on our estimate of expected and future product 
demand.  Our estimates of future product demand will differ from actual 
demand and, as such, our estimate of the provision required for excess and 
obsolete inventory will change, which we will record in the period such 
determination was made. Raw material, work in process and finished goods 
inventory associated with programs cancelled by customers are fully reserved 
for as obsolete.  Reductions in obsolescence reserves are recognized when 
realized through disposal of reserved items, either through sale or 
scrapping.

Goodwill. We recorded goodwill in connection with our acquisition of a 40% 
interest in Parlex Shanghai and our 1999 acquisition of Parlex Dynaflex 
Corporation ("Dynaflex").  We account for goodwill under the provisions of 
SFAS No. 142, Goodwill and Other Intangible Assets.  Under the provisions 
of SFAS No. 142, if an intangible asset is determined to have an indefinite 
useful life, it shall not be amortized until its useful life is determined 
to be no longer indefinite.  An intangible asset that is not subject to 
amortization shall be tested for impairment annually or more frequently if 
events or changes in circumstances indicate that the asset might be 
impaired. Goodwill is not amortized but is tested for impairment, for each 
reporting unit, on an annual basis and between annual tests in certain 
circumstances.  In accordance with the guidelines in SFAS No. 142, we 
determined we have one reporting unit.  We evaluate goodwill for impairment 
by comparing our market capitalization, as adjusted for a control premium, 
to our recorded net asset value. If our market capitalization, as adjusted 
for a control premium, is less than our recorded net asset value, we will 
further evaluate the implied fair value of our goodwill with the carrying 
amount of the goodwill, as required by SFAS No. 142, and we will record an 
impairment charge against the goodwill, if required, in our results of 
operations in the period such determination was made. Since our market 
capitalization, as adjusted, exceeded our recorded net asset value upon 
adoption of SFAS No. 142 and at the subsequent annual impairment analysis 
dates, we have concluded that no impairment adjustments were required at 
the time of adoption or at the annual impairment analysis date.  The 
carrying value of the goodwill was $1,157,510 at March 31, 2005 and June 
30, 2004.  Based on the current recorded net asset value, we may be 
required to record a charge for the impairment of our goodwill in the 
future should our stock price consistently remain at a price of less than 
approximately $5.00 per share.

Income Taxes. We determine if our deferred tax assets and liabilities are 
realizable on an ongoing basis by assessing our valuation allowance and by 
adjusting the amount of such allowance, as necessary.  In the determination 
of the valuation allowance, we have considered future taxable income and the 
feasibility of tax planning initiatives.  Should we determine that it is more 
likely than not that we will realize certain of our net deferred tax assets 
for which we previously provided a valuation allowance, an adjustment would 
be required to reduce the existing valuation allowance. In addition, we 
operate within multiple taxing jurisdictions and are subject to audit in 
these jurisdictions. These audits can involve complex issues, which may 
require an extended period of time for resolution. Although we believe that 
we have adequately considered such issues, there is the possibility that the 
ultimate resolution of such issues could have an adverse effect on the 
results of our operations.


  22


Off-Balance Sheet Arrangements. We have not created, and are not party to, 
any special-purpose or off-balance sheet entities for the purpose of raising 
capital, incurring debt or operating parts of our business that are not 
consolidated into our financial statements. We do not have any arrangements 
or relationships with entities that are not consolidated into our financial 
statements that are reasonably likely to materially affect our liquidity or 
the availability of capital resources, except as may be set forth below 
under "Liquidity and Capital Resources."  Our obligations under operating 
leases are disclosed in the Notes to our financial statements.

Results of Operations
---------------------

The following table sets forth, for the periods indicated, selected items 
in our statements of operations as a percentage of total revenue. You 
should read the table and the discussion below in conjunction with our 
Condensed Consolidated Financial Statements and the Notes thereto.




                                                        Three Months Ended                     Nine Months Ended
                                                 March 31, 2005     March 28, 2004     March 31, 2005     March 28, 2004

                                                                                                 
Total revenues                                      100.0 %            100.0 %            100.0 %            100.0 %
Cost of products sold                                91.0 %             91.8 %             87.6 %             89.6 %
                                                    -----              -----              -----              -----

Gross profit                                          9.0 %              8.2 %             12.4 %             10.4 %
Selling, general and administrative expenses         14.1 %             16.5 %             14.7 %             17.3 %
                                                    -----              -----              -----              -----

Operating loss                                       (5.1)%             (8.3)%             (2.3)%             (6.9)%
Loss from operations before income taxes
 and minority interest                               (7.7)%            (11.0)%             (4.7)%             (9.7)%
                                                    -----              -----              -----              -----
Net loss                                             (7.8)%            (11.2)%             (5.0)%             (9.9)%
                                                    -----              -----              -----              -----


Three Months Ended March 31, 2005 Compared to Three Months Ended March 28, 2004
-------------------------------------------------------------------------------

Total Revenues.  Total revenues for the three months ended March 31, 2005 
were $29.1 million versus $23.2 million for the three months ended March 
28, 2004.  This represents an increase of $6.0 million or 26%.  Solid 
revenue growth was recorded in each of our lines of business with the 
exception of our laminated cable operations which were essentially flat 
year over year. Bookings in the laminated cable business were below plan 
for a third consecutive quarter.  Increased competition from Asian 
competitors continues to have an adverse effect on large volume 
opportunities.  We believe revenues will improve with additional sales 
focus coupled with the purchase of a new high speed laminator.  We are 
looking to lease this equipment for installation in our Mexico facility.  
This capital acquisition will provide improved pitch and tolerance 
capabilities and is anticipated to be installed in the fourth quarter.

Revenues from our China operations increased to $10.7 million from $7.3 
million in the prior year representing a 47% increase for the same period 
year over year.  Strong growth occurred in the computer and peripheral, 
automotive and telecommunications markets year over year.  Revenues from 
our smart card business were well below expectations caused by delayed 
orders from Infineon.  No production orders were received thereby leaving 
our manufacturing line essentially idle other than for prototyping.  
Product qualification problems with Infineon's end customer triggered the 
delay.  New volume production orders were placed in April 2005.  Revenue in 
our China operations from markets such as electronic identification is 
particularly important in our third quarter given the cyclical nature of 
other markets served.  Markets such as computer and peripherals are 
adversely affected by seasonally lower demand coupled with design change 
implementations occurring in the third quarter.  In addition, Chinese New 
Year holidays interrupt third quarter production schedules.  Polymer thick 
film revenues totaled $8.9 million representing a 9% increase versus the 
same period of the prior year.  Revenue increases continue to be driven by 
accelerated growth in


  23


the medical market, particularly in disposable medical devices.  Strong 
performance occurred in particular in our United States manufacturing 
operations.  We began to increase production on several new appliance 
orders late in the third quarter.

Revenues in our Methuen, Massachusetts multilayer manufacturing operations 
increased 43% versus the same period of the prior year.  Steady growth in 
military /aerospace programs has contributed to an improved backlog of base 
business.  In July 2004, we began transitioning multilayer flex 
manufacturing from Delphi Corporation's Irvine, California facility to our 
Methuen operation under a strategic sourcing relationship.  We continued to 
make progress with this transition during the third quarter although we 
remain two quarters away from completion.  Increased manufacturing levels 
in our Methuen facility are critical to improving absorption within a 
significantly under utilized operation.

Cost of Products Sold.  Cost of products sold was $26.5 million, or 91% of 
total revenues, for the three months ended March 31, 2005, versus $21.3 
million, or 92% of total revenues, for the three months ended March 28, 
2004.  Slight reduction in the cost of products sold as a percentage of 
total revenues, and a corresponding improvement in our gross margin, was in 
large part driven by manufacturing volume increases.  Revenues increased 
26% for the same period year over year, resulting in improved factory 
utilization and better absorption of fixed overhead costs.  Fixed and 
variable manufacturing overhead decreased from 41% of revenues in the third 
quarter of fiscal 2004 to 40% of revenues for the third quarter of fiscal 
2005.  In addition to improved utilization, overhead as a percentage of 
revenue was favorably impacted by a continued shift of manufacturing to our 
low cost China operations. 

Reductions in manufacturing overhead were in part offset by increases in 
material costs.  Raw material costs and in particular copper prices 
escalated more than 25% during the past fiscal year.  Similarly, base 
flexible materials such as polyimide rose substantially during the year 
with worldwide supply constraints.  In many cases this has forced us to 
increase our pricing to our customers.  Long term supply commitments 
however, do not always permit price increases, at least in the short term.  
Rising material costs continues to place adverse pressure on gross margins.

Margins were also adversely impacted by the lack of production orders for 
our smart card line.  In addition to fixed costs such as depreciation and 
facility expense, idle labor was essentially a fixed cost for this quarter.  
Lower production levels elsewhere in our China operations provided little 
opportunity to leverage resources.  Substantial investment in training 
coupled with production commencing in April required retaining the current 
workforce. 

The Methuen multilayer operation continues to experience low capacity 
utilization and, correspondingly, significant unfavorable manufacturing 
variances.  We currently estimate our multilayer utilization to be 
approximately 40%.  Revenue in the multilayer operation was severely 
impacted by the rapid decline of the telecommunications network 
infrastructure market. In fiscal 2001 this market represented over 75% of 
multilayer revenues.  By the first quarter of fiscal 2003, revenues in this 
market were immaterial.  We have seen little or no recovery in this market 
to date.  Over the past two years we have sought to replace this revenue by 
targeting markets demanding complex North American design and manufacturing 
solutions.  We believe the military aerospace and medical markets represent 
two growing markets demanding such services.  In addition to a focused 
corporate sales effort targeting new business development, we have 
continued to evaluate opportunities to acquire business, particularly in 
the highly fragmented military aerospace market.  In June 2004, we entered 
into a strategic sourcing agreement with Delphi Corporation.  Under the 
arrangement, Delphi Corporation will transfer production of its multilayer 
flexible circuit manufacturing to our Methuen operation.  In the third 
quarter of fiscal 2005 shipments totaled approximately $529,000. We expect 
manufacturing to increase significantly over the remainder of the 2005 
fiscal year improving facility utilization and further reducing multilayer 
operating losses.


  24


Selling, General and Administrative Expenses.  Selling, general and 
administrative expenses were $4.1 million for the three months ended March 
31, 2005 versus $3.8 million for the comparable period in the prior year.  
Increases can be primarily attributed to higher commissions of $200,000 due 
to increases in revenues, higher public company costs of $200,000 including 
legal, audit and insurance, continued escalation of fringe costs of 
$100,000 in particular medical expenses, and infrastructure investment in 
China of $100,000.  These increases were in part offset by a reduction in 
bad debt expense of $300,000 associated with a settlement of an accounts 
receivable dispute.

Interest Income.  Interest income was $17,000 for the three months ended 
March 31, 2005 compared to $2,000 for the three months ended March 28, 
2004.  The balance represents interest income on our cash balances.

Interest Expense.  Interest expense was $762,000 for the three months ended 
March 31, 2005 compared to $642,000 for the three months ended March 28, 
2004.  Interest expense for the period ended March 31, 2005 included 
$423,000 for amortized deferred financing costs and $83,000 for interest 
payable in common stock related to issuance of convertible notes in July 
2003.  The deferred financing costs are associated with the sale-leaseback 
of our Methuen, Massachusetts facility, the Loan Agreement with Silicon 
Valley Bank and sale of our convertible subordinated notes.  The balance of 
the interest expense represents interest incurred on our short and long 
term bank borrowings and deferred compensation. 

Our loss before income taxes and the minority interest in our Chinese joint 
venture, Parlex Shanghai, was $2.2 million in the three months ended March 
31, 2005 compared to $2.6 million in the three months ended March 28, 2004.  
We own 90.1% of the equity interest in Parlex Shanghai and, accordingly, 
include Parlex Shanghai's results of operations, cash flows and financial 
position in our consolidated financial statements.

Income Taxes. Our effective tax rate was approximately 0.2% for the three 
months ended March 31, 2005, versus 1.9% for the three months ended March 
28, 2004.  Our effective tax rate is impacted by the proportion of our 
estimated annual income being earned domestically versus in foreign tax 
jurisdictions, the generation of tax credits and the recording of any 
valuation allowance.  As a result of our history of operating losses, 
uncertain future operating results, and the past non-compliance with 
certain of our debt covenants requirements, which have subsequently been 
waived, we determined that it is more likely than not that certain historic 
and current year income tax benefits will not be realized.  Consequently, 
we recorded no income tax benefits on our U.S. operating losses during the 
three months ended March 31, 2005.  In fiscal 2003, we established a 
valuation allowance against all of our remaining net U.S. deferred tax 
assets.

Nine months Ended March 31, 2005 Compared to Nine months Ended March 28, 2004
-----------------------------------------------------------------------------

Total Revenues.  Total revenues for the nine months ended March 31, 2005 
were $90.8 million versus $66.4 million for the nine months ended March 28, 
2004.  This represents an increase of $24.4 million or 37%. Increases were 
recorded in each of our business units with particularly strong growth in 
our China (56%), Multilayer (48%) and Polymer Thick Film (21%) operations.

Strong revenues were recorded in our China operations for the first nine 
months of fiscal 2005.  Our China operation's sales increased to 42% of the 
Company's total revenues versus 37% for the first nine months of fiscal 
2004. Foreign sourced revenues increased to 55% of total revenues for the 
first nine months of fiscal 2005.  China revenue increases of $13.8 
million, were driven by strong sales in the computer peripherals, wireless 
telecom, automotive, and electronic identification markets. Hewlett Packard 
remained our largest China customer and only customer representing greater 
than 10% of total Company revenues.  Total revenues from Hewlett Packard 
for the first nine months were $18.1 million.  New design awards for 
calendar year 2005 are likely to sustain our preferred supplier position 
with Hewlett Packard for the next twelve months.  Polymer thick film 
revenues increased $4.7 million over the same period of the prior year with 
growth occurring primarily in the disposable medical market.  Several new 
program design wins in the 


  25


appliance market will contribute to growth here over the next twelve 
months.  Multilayer revenues increased $4.5 million versus the same period 
of the prior year.  Focused efforts to re-develop our military aerospace 
business have begun to show improved results.  Raytheon Company remained 
our single largest multilayer customer in the second quarter with solid 
growth from Delphi Corporation and BAE Systems.

Cost of Products Sold.  Cost of products sold was $79.5 million, or 88% of 
total revenues, for the nine months ended March 31, 2005, versus $59.5 
million, or 90% of total revenues, for the nine months ended March 28, 
2004.  Increased capacity utilization in China resulted in margin 
improvement.  Gross margins in China were 19% for the first nine months of 
fiscal 2005 versus 18% for the comparable period of the prior year.  
However, margins were adversely affected by the suspended production of our 
smart card products. Delayed orders from Infineon caused by product 
qualification problems with their end customer resulted in idle production 
for the quarter.  Polymer thick film gross margins decreased from 17% to 
14% for the first nine months of the fiscal year.  Decreases can be 
primarily attributed to an increase in lower margin assembly business 
during fiscal 2005.  Margins on assembly activities are typically 8% to 10% 
versus polymer thick film circuit fabrication which typically yields 
margins greater than 20%.  Our Methuen facility continued to experience low 
capacity utilization and correspondingly, significant unfavorable 
manufacturing variances.  Continued growth in our multi-layer business, 
primarily in the military and medical markets, and the relocation of our 
laminated cable operations from Salem, New Hampshire to Methuen 
Massachusetts, which was completed in January 2003, have improved factory 
utilization substantially.  We continue to drive operational improvements 
which we believe will reduce breakeven revenue levels.  These include yield 
and process improvement programs as well as raw material cost reduction 
initiatives.  In addition, we have significantly strengthened the 
multilayer management team over the past year with new hires in management, 
quality and production control.

Selling, General and Administrative Expenses.  Selling, general and 
administrative expenses were $13.3 million for the nine months ended March 
31, 2005 versus $11.5 million for the comparable period in the prior year.  
Increases can be primarily attributed to higher commissions of $700,000 on 
a 37% increase in revenues, higher public company costs of $500,000 
including legal, audit and insurance, continued escalation of fringe costs 
which amounted to $400,000 with a particular increase in medical expenses, 
and infrastructure investment in China of $500,000.  These increases were 
in part offset by a reduction in bad debt expense of $300,000 associated 
with the settlement of an accounts receivable dispute.

Interest Income.  Interest income was $57,000 for the nine months ended 
March 31, 2005 compared to $9,000 for the nine months ended March 28, 2004.  
Interest income for the nine months ended March 31, 2005 included $26,000 
of interest income on our tax refunds.  The balance represents interest 
income on our cash balances.

Interest Expense.  Interest expense was $2.3 million for the nine months 
ended March 31, 2005 and $1.8 million for the nine months ended March 28, 
2004.  Interest expense for the nine months ended March 31, 2005 included 
approximately $1.3 million for amortized deferred financing costs and 
$250,000 for interest payable in common stock related to issuance of 
convertible notes in July 2003.  The deferred financing costs are 
associated with the sale-leaseback of our Methuen, Massachusetts facility, 
the Loan and Security Agreement with Silicon Valley Bank and sale of our 
convertible subordinated notes.  The balance of the interest expense 
represents interest incurred on our short and long term bank borrowings and 
deferred compensation.

Our loss before income taxes and the minority interest in our Chinese 
venture, Parlex Shanghai, was $4.3 million in the nine months ended March 
31, 2005 compared to $6.5 million in the nine months ended March 28, 2004.  
We own 90.1% of the equity interest in Parlex Shanghai and, accordingly, 
include Parlex Shanghai's results of operations, cash flows and financial 
position in our consolidated financial statements.


  26


Income Taxes. Our effective tax rate was approximately 2.8% for the nine 
months ended March 31, 2005 versus an effective tax rate of 0.7% for the 
nine months ended March 28, 2004.  Our effective tax rate is impacted by 
the proportion of our estimated annual income being earned domestically 
versus in foreign tax jurisdictions, the generation of tax credits and the 
recording of any valuation allowance.  As a result of our recent history of 
operating losses, uncertain future operating results, and the past non-
compliance with certain of our debt covenants requirements, we determined 
that it is more likely than not that certain historic and current year 
income tax benefits will not be realized.  Consequently, we recorded no 
income tax benefits on our U.S operating losses during the nine months 
ended March 31, 2005 and March 28, 2004.  In fiscal 2003, we established a 
valuation allowance against all of our remaining net U.S. deferred tax 
assets.

Liquidity and Capital Resources
-------------------------------

As of March 31, 2005, we had approximately $3.9 million in cash and cash 
equivalents.

Net cash used in operations during the nine months ended March 31, 2005 was 
$1.5 million. This compares to net cash used in operations of $9.2 million 
for the same period of the prior year.  Net operating losses of $4.5 
million, after adjustment for minority interest, interest payable in common 
stock, depreciation and amortization, provided $800,000 of operating cash.  
Operations consumed $2.3 million of working capital.  Cash used for working 
capital included $2.8 million for inventory and $600,000 for accounts 
payable partially offset by $400,000 from accounts receivable, and $700,000 
from other working capital sources.  Inventory increases occurred in raw 
material of $2.0 million, which included the purchase of connectors and 
assembly components, and work in process of $1.1 million.  The growth in 
inventory is in part a function of our expanded value-add strategy.  
Increasingly, customers are demanding more complex sub-assemblies from 
their interconnect providers.  Assembly on flex materials can be 
challenging and when executed well, a differentiation opportunity exists to 
distinguish us from our competition.  However, a cost to this business 
opportunity is a significant increase in inventory levels and the 
associated working capital requirement.  From an industry perspective, we 
see this trend toward increased sub-assembly requirements continuing to 
grow.

Investing activities consumed $707,000 of net cash during the nine months 
ended March 31, 2005, primarily to purchase capital equipment.  As of March 
31, 2005, we had an additional $952,000 of capital equipment financed under 
our accounts payable.  We have implemented a plan to control our capital 
expenditures in order to enhance cash flows.  Cash provided by financing 
activities was $4.4 million for the nine months ended March 31, 2005, 
including $1.5 million that represented the net repayments and borrowings 
on our bank debt.  We received net proceeds totaling $2.1 million 
associated with the Methuen sale-leaseback financing of which $1.9 million 
was principal, $85,000 was interest, and $275,000 was for an earn-out, 
offset by lease payments of 169,000.  In addition, we received $1.0 million 
from Infineon Technologies as a deposit for our joint venture agreement.  
Upon closing of the joint venture, currently anticipated to be in late June 
2005, Infineon will pay the balance due of $2.0 million.  Closing is 
predicated on obtaining a business license and other necessary governmental 
approvals for the joint venture company in the People's Republic of China.  
Should we be unable to close the transaction, the $1.0 million deposit is 
required to be re-paid.

Improved financial performance in the first quarter of 2005 significantly 
reduced operating losses and cash used in operations.  Increased sales in 
the first nine months of fiscal 2005, however, have placed additional cash 
demands on working capital with growth in inventory.  The strong credit 
ratings of our large OEM and EMS customer base have allowed us to 
successfully finance this growth through our asset based working capital 
lines of credit.  We recently completed stand alone financing for our China 
operations through a new line of credit with Bank of China that will allow 
us to continue financing our growth plans.  See "Factors That May Affect 
Future Results".

In response to the worldwide downturn in the electronics industry, we have 
taken a series of actions to reduce operating expenses and to restructure 
operations, consisting primarily of reductions in workforce and 


  27


consolidation of manufacturing operations.  During 2004, we transferred our 
high volume automated surface mount assembly line from our Cranston, Rhode 
Island facility to China.  In August 2004, we announced a new strategic 
relationship with Delphi Corporation to supply all multilayer flex and 
rigid flex circuits which were previously manufactured by Delphi 
Corporation in its Irvine, California facility.  We continue to implement 
plans to control operating expenses, inventory levels, and capital 
expenditures as well as manage accounts payable and accounts receivable to 
enhance cash flow and return us to profitability. Our plans include the 
following actions: 1) continuing to consolidate manufacturing facilities; 
2) continuing to transfer certain manufacturing processes from our domestic 
operations to lower cost international manufacturing locations, primarily 
those in the People's Republic of China; 3) expanding our products in the 
home appliance, cell phone and handheld devices, medical, military and 
aerospace, and electronic identification markets; 4) continuing to monitor 
general and administrative expenses; and 5) continuing to evaluate 
opportunities to improve capacity utilization by either acquiring 
multilayer flexible circuit businesses or entering into strategic 
relationships for their production.

In fiscal years 2003 and 2004, we entered into a series of alternative 
financing arrangements to partially replace or supplement those currently 
in place in order to provide us with financing to support our current 
working capital needs.  Working capital requirements, particularly those to 
support the growth in our China operations, consumed $10.4 million of a 
total of $11.4 million of cash used in operations during 2004.  In 
September 2004, we secured a new $5.0 million asset based working capital 
agreement with the Bank of China which provides stand alone financing for 
our China operations. In addition, in May 2004 we received net proceeds of 
approximately $2.95 million from the sale of our Series A convertible 
preferred stock. In December 2004, we entered into a joint venture 
agreement with Infineon Technologies Asia Pacific Pte Ltd. Upon execution 
of the joint venture agreement, we received a $1.0 million deposit and will 
receive an additional $2.0 million once certain People's Republic of China 
government approvals are received for the new joint venture company and the 
transaction closes. Also in December 2004, we executed a loan modification 
with Silicon Valley Bank extending the term to July 2006 and increasing the 
borrowing limit to $12.0 million.  In February 2005, the landlord for our 
Methuen, Massachusetts facility completed the sale of the property to a 
third party.  Under terms of the transaction, we received cash of 
approximately $2.2 million. The proceeds represented repayment of the 
outstanding financing we originally provided under the initial sale and a 
settlement on amounts due under the terms of an earn out.  We continue to 
evaluate alternative financing opportunities to further improve our 
liquidity and to fund working capital needs.

We believe that our cash on hand and the cash expected to be generated from 
operations will be sufficient to enable us to meet our operating 
obligations through March 2006. If we require additional or new external 
financing to repay or refinance our existing financing obligations or fund 
our working capital requirements, we believe that we will be able to obtain 
such financing.  Failure to obtain such financing may have a material 
adverse impact on our operations.  At March 31, 2005, we were not in 
compliance with certain financial covenants of our loan agreement with 
Silicon Valley Bank.  We have received a waiver from the bank for our non-
compliance at March 31, 2005 and the bank has continued to allow us to borrow 
against the loan agreement.  In the future, we expect to be in compliance with 
all of our bank covenants.  Our third quarter ending March 31 is typically 
adversely impacted by the cyclical nature of certain strategic markets we 
serve.  This is particularly true in the computer and peripheral market where 
annual model year design change occurs in January. Coupled with the Chinese 
New Year holidays, the third quarter is historically the weakest for our 
rapidly growing China operations.  New customer orders began increasing in 
March 2005.  As such, we anticipate a strong recovery in volume production 
during the fourth quarter ending June 30, 2005. 

Series A Convertible Preferred Stock - On June 8, 2004, we completed a 
private placement of 40,625 shares of Series A Convertible Preferred Stock 
and warrants at $80.00 per unit for proceeds of approximately $2.95 
million, net of issuance costs of approximately $300,000.  For additional 
information relating to the Series A Convertible Preferred Stock, please 
see Note 9 to the Notes to Unaudited Condensed Consolidated Financial 
Statements.


  28


Loan and Security Agreement (the "Loan Agreement") - We executed the Loan 
Agreement with Silicon Valley Bank on June 11, 2003 and since such date we 
entered into eight amendments to the Loan Agreement.  The Loan Agreement 
provided Silicon Valley Bank with a secured interest in substantially all 
of our assets.  As subsequently amended under the Loan Agreement we may 
borrow up to $12.0 million, based on a borrowing base of eligible accounts 
receivable.  Borrowings may be used for working capital purposes only.  The 
Loan Agreement allows us to issue letters of credit, enter into foreign 
exchange forward contracts and incur obligations using the bank's cash 
management services up to an aggregate limit of $1.0 million, which reduces 
our availability for borrowings.  The Loan Agreement contains certain 
restrictive covenants, including but not limited to, limitations on debt 
incurred by our foreign subsidiaries, acquisitions, sales and transfers of 
assets, and prohibitions against cash dividends, mergers and repurchases of 
stock without prior bank approval.  The Loan Agreement also has financial 
covenants, which among other things require us to maintain $750,000 in 
minimum cash balances or excess availability under the Loan Agreement.

On December 22, 2004, we executed a Seventh Loan Modification Agreement 
(the "Seventh Modification Agreement") with Silicon Valley Bank.  The 
Seventh Modification Agreement increased our maximum borrowings to $12.0 
million based upon a borrowing base of eligible account receivables plus 
the lesser of 20% of eligible inventory or $1.0 million.  The Seventh 
Modification Agreement reduced the interest rate on borrowings to the 
bank's prime rate (5.75% at March 31, 2005) plus 2.00% (decreasing to prime 
plus 1.25% after two consecutive quarters of positive operating income and 
further decreasing to prime plus 0.50% after two consecutive quarters of 
positive net income, respectively).  The Seventh Modification Agreement 
changed the EBITDA requirement to $500,000 on a three month trailing basis 
as of the period ending December 31, 2004 and each month thereafter until 
May 31, 2005 and to $750,000 on a three month trailing basis as of the 
period ending June 30, 2005 and each month thereafter.  The Seventh 
Modification Agreement also extended the maturity date of the Loan 
Agreement from July 11, 2005 to July 11, 2006.  On May 10, 2005, we 
executed an Eighth Loan Modification Agreement (the "Eighth Modification 
Agreement") with Silicon Valley Bank.  The Eighth Modification Agreement 
changed the EBITDA requirement to $1.00 on a monthly basis as of the 
periods ending April 30, 2005 and May 31, 2005 and $750,000 on a trailing 
three month basis as of the period ending June 30, 2005 and each month 
thereafter.  At March 31, 2005, we had available borrowing capacity under 
the Loan Agreement of approximately $4.8 million.  Since the available 
borrowing capacity exceeded $750,000 at March 31, 2005, none of our cash 
balance was subject to restriction at March 31, 2005.  We have received a 
written waiver from the bank for our non-compliance at March 31, 2005 and 
the bank has continued to allow us to borrow against the Loan Agreement.

The Loan Agreement includes both a subjective acceleration clause and a 
lockbox arrangement that requires all lockbox receipts to be used to pay 
down the revolving credit borrowings.  Accordingly, borrowings under the 
Loan Agreement have been classified as current liabilities in the 
accompanying consolidated balance sheets as of March 31, 2005 and June 30, 
2004 as required by Emerging Issues Task Force Issue No. 95-22, "Balance 
Sheet Classification of Borrowings Outstanding Under Revolving Credit 
Agreements that include both a Subjective Acceleration Clause and a Lockbox 
Arrangement".  However, such borrowings will be excluded from current 
liabilities in future periods and considered long-term obligations if: 1) 
such borrowings are refinanced on a long-term basis, 2) the subjective 
acceleration terms of the Loan Agreement are modified, or 3) such 
borrowings will not require the use of working capital within one year.


  29


Parlex Shanghai Term Notes - A summary of the Parlex Shanghai term notes 
are as follows:




                                                                      March 31, 2005
                                                                      (in millions)

                                                                        
Due March 2006 at 5.58% and guaranteed by Parlex Interconnect              $2.5
Due January 2006 at LIBOR plus 2.5% and guaranteed by Parlex Asia           1.5
Due June 2005 at 5.58% and guaranteed by Parlex Interconnect                1.3
Due June 2005 at 5.58% and guaranteed by Parlex Interconnect                1.0
Due April 2005 at 5.31% and guaranteed by Parlex Interconnect               0.7
Due March 2006 at 5.58% and guaranteed by Parlex Interconnect               0.6
                                                                           ----
Total Parlex Shanghai term notes                                           $7.6
                                                                           ====


Subsequent to March 31, 2005, Parlex Shanghai renewed its $700,000 short-
term note due April 2005.  The note has been extended until April 2006 at 
an interest rate of 5.58%.

Parlex Interconnect Term Notes - On October 28, 2004, Parlex Interconnect 
entered into a $605,000 short-term bank note, due October 27, 2005, bearing 
interest at 5.31% and guaranteed by Parlex Shanghai.

Parlex Asia Banking Facility - On September 15, 2004, Parlex Asia entered 
into an agreement with the Bank of China for a $5 million banking facility 
which we guaranteed. Under the terms of the banking facility, Parlex Asia 
may borrow up to $5.0 million based on a borrowing base of eligible account 
receivables. The banking facility bears interest at LIBOR plus 2.00%.  
Amounts outstanding as of March 31, 2005 totaled $1.8 million.

Finance Obligation on Sale Leaseback of Methuen Facility - In June 2003, we 
entered into a sale-leaseback transaction pursuant to which we sold our 
corporate headquarters and manufacturing facility located in Methuen, 
Massachusetts (the "Methuen Facility") for a purchase price of $9.0 
million.  The purchase price consisted of $5.35 million in cash at the 
closing, a promissory note in the amount of $2.65 million (the "Note") and 
up to $1.0 million in additional cash under the terms of an Earn Out Clause 
(the "Earn Out").  In June 2004, we received $750,000 reducing the 
principal balance of the Note to $1.9 million.  On February 25, 2005, the 
landlord sold the Methuen Facility and paid to us the remaining principal 
balance due on the Note of $1.9 million and agreed to pay the sum of 
$675,000 in full settlement of the Earn Out.  Per the terms of the sale of 
the Methuen Facility, $400,000 of the $675,000 was placed in escrow as 
security for our remaining lease obligations.

As the repurchase option contained in the lease and the receipt of the Note 
from the buyer provide us with a continuing involvement in the Methuen 
Facility, we have accounted for the sale-leaseback of the Methuen Facility 
as a financing transaction. Accordingly, we continue to report the Methuen 
Facility as an asset and continue to record depreciation expense. We record 
all cash received under the transaction as a finance obligation. The Note 
and related interest thereon, and the additional cash under the terms of 
the Earn Out, were recorded as an increase to the finance obligation as 
cash payments were received. We record the principal portion of the monthly 
lease payments as a reduction to the finance obligation and the interest 
portion of the monthly lease payments is recorded as interest expense. The 
closing costs for the transaction have been capitalized and are being 
amortized as interest expense over the initial 15-year lease term. Upon 
expiration of the repurchase option in June 2015, we will reevaluate our 
accounting to determine whether a gain or loss should be recorded on this 
sale-leaseback transaction. 

Convertible Subordinated Notes - On July 28, 2003, we sold an aggregate 
$6.0 million of our 7% convertible subordinated notes (the "Notes") with 
attached warrants to several institutional investors. We


  30


received net proceeds of approximately $5.5 million from the transaction, 
after deducting approximately $500,000 in finders' fees and other 
transaction expenses. Net proceeds were used to pay down amounts borrowed 
under our Loan Agreement and utilized for working capital needs. No 
principal payments are due until maturity on July 28, 2007. The Notes are 
unsecured.

The Notes bear interest at a fixed rate of 7%, payable quarterly in shares 
of our common stock. The number of shares of common stock to be issued is 
calculated by dividing the accrued quarterly interest by a conversion 
price, which was initially established at $8.00 per share.  The conversion 
price is subject to adjustment in the event of stock splits, dividends and 
certain combinations.

Interest expense is recorded quarterly based on the fair value of the 
common shares issued. Accordingly, interest expense may fluctuate from 
quarter to quarter. We have concluded that the interest feature does not 
constitute an embedded derivative as it does not currently meet the 
criteria for classification as a derivative. We recorded accrued interest 
payable on the Notes of $83,331 within stockholders' equity at March 31, 
2005, as the interest is required to be paid quarterly in the form of 
common stock.  Based on the conversion price of $8.00 per common share, we 
issued a total of 74,963 shares of common stock from October 2003 to 
January 2005 in satisfaction of the previously recorded interest.  We also 
issued 13,123 shares of common stock in April 2005 as payment for the 
interest accrued as of March 31, 2005.

The Notes contained a beneficial conversion feature reflecting an effective 
initial conversion price that was less than the fair market value of the 
underlying common stock on July 28, 2003.  The fair value of the beneficial 
conversion feature was approximately $1.035 million, which has been 
recorded as an increase to additional paid-in capital and as an original 
issue discount on the Notes which is being amortized to interest expense 
over the four year life of the Notes.

After two years from the date of issuance, we have the right to redeem all, 
but not less than all, of the Notes at 100% of the remaining principal of 
Notes then outstanding, plus all accrued and unpaid interest, under certain 
conditions.  After three years from the date of issuance, the holder of any 
of the Notes may require us to redeem the Notes in whole, but not in part.  
Such redemption shall be at 100% of the remaining principal of such Notes, 
plus all accrued and unpaid interest.  In the event of a Change in Control 
(as defined therein), the holder has the option to require that the Notes 
be redeemed in whole (but not in part), at 120% of the outstanding unpaid 
principal amount, plus all unpaid accrued interest.

Factors That May Affect Future Results
--------------------------------------

Our prospects are subject to certain uncertainties and risks.  Our future 
results may differ materially from the current results and actual results 
could differ materially from those projected in the forward-looking 
statements as a result of certain risk factors, other one-time events and 
other important factors disclosed previously and from time to time in our 
other filings with the Securities and Exchange Commission.

If we cannot obtain additional financing when needed, we may experience a 
material adverse impact on our operations.

We may need to raise additional funds either through borrowings or further 
equity financing.  We may not be able to raise additional capital on 
reasonable terms, or at all.  The cash expected to be generated will not be 
sufficient to enable us to meet our financing and operating obligations 
over the next twelve months based on current growth plans.  If we cannot 
raise the required funds when needed, we may experience a material adverse 
impact on our operations.


  31


Our business has been, and could continue to be, materially adversely 
affected as a result of general economic and market conditions.

We are subject to the effects of general global economic and market 
conditions.  Our operating results have been materially adversely affected 
as a result of recent unfavorable economic conditions and reduced 
electronics industry spending on both a domestic and worldwide basis.  
Though we have experienced some general market spending improvement during 
the past quarter, should market conditions not continue to improve, our 
business, results of operations or financial condition could continue to be 
materially adversely affected.

We have at times relied upon waivers from our lenders and amendments or 
modifications to our financing agreements to avoid any acceleration of our 
debt payments.  In the event that we are not in compliance with our 
financial covenants in the future, we cannot be certain our lenders will 
grant us waivers or execute amendments on terms, which are satisfactory to 
us.  If such waivers are not received, our debt is immediately callable.

Since entering into our current loan arrangement with our primary lender, 
Silicon Valley Bank, in June of 2003, we have requested and received 
several waivers relating to our failure to comply with certain financial 
covenants under our loan arrangement, most recently for the period ended 
March 31, 2005.  In conjunction with the waivers, we have also executed 
several modifications of our loan arrangement, which have primarily 
resulted in easing our covenant compliance requirements, but have also 
increased our costs of borrowing.  Although we do not believe Silicon 
Valley Bank will exercise any right it may have to immediately call our 
debt if we fail to comply with our financial covenants, we cannot guarantee 
that they will not do so.  We are currently in compliance with all of our 
financial covenants, as amended.

The issuance of our shares upon conversion of outstanding convertible 
notes, conversion of preferred stock and upon exercise of outstanding 
warrants may cause significant dilution to our stockholders and may have an 
adverse impact on the market price of our common stock.

On July 28, 2003, we completed a private placement of our 7% convertible 
subordinated notes (and accompanying warrants) in an aggregate subscription 
amount of $6 million.  The conversion price of the convertible notes and 
the exercise price of the warrants is $8.00 per share.  In addition, on 
June 8, 2004, we completed a private placement of 40,625 shares of our 
Series A Convertible Preferred Stock (the "Preferred Stock") (and 
accompanying warrants), for $80.00 per share, or $3.25 million in the 
aggregate. Each share of Preferred Stock may be converted at any time at 
the option of the holder of the Preferred Stock for 10 shares of common 
stock, and the exercise price of the warrants is $8.00 per share.  For 
additional information relating to the sale of these securities, please see 
"Market for Registrant's Common Equity and Related Stockholder Matters - 
Recent Sales of Unregistered Securities - 7% Convertible Subordinated Notes 
and Warrants" and "Series A Preferred Stock and Warrants" in our Form 10-K 
filing for the period ended June 30, 2004.

The issuance of our shares upon conversion of the convertible subordinated 
notes and/or Preferred Stock, and exercise of the warrants, and their 
resale by the holders thereof will increase our publicly traded shares.  
These re-sales could also depress the market price of our common stock. We 
will not control whether or when the holders of these securities elect to 
convert or exercise their securities for common stock.  In addition, the 
perceived risk of dilution may cause our stockholders to sell their shares, 
which would contribute to a downward movement in the stock price of our 
common stock.  Moreover, the perceived risk of dilution and the resulting 
downward pressure on our stock price could encourage investors to engage in 
short sales of our common stock.  By increasing the number of shares 
offered for sale, material amounts of short selling could further 
contribute to progressive price declines in our common stock.


  32


Substantial leverage and debt service obligations may adversely affect us.

We have a substantial amount of indebtedness.  As of March 31, 2005, we had 
approximately $28.0 million of consolidated debt of which $14.3 million is 
due within one year.  Our substantial level of indebtedness increases the 
possibility that we may be unable to generate sufficient cash to pay when 
due the principal of, interest on, or other amounts due with respect to our 
indebtedness.  Approximately 26% of our outstanding indebtedness bears 
interest at floating rates.  As a result, our interest payment obligations 
on such indebtedness will increase if interest rates increase.

Our substantial leverage could have significant negative consequences on 
our financial condition, results of operations, and cash flows, including:

*     Impairing our ability to meet one or more of the financial ratios 
      contained in our debt agreements or to generate cash sufficient to 
      pay interest or principal, including periodic principal amortization 
      payments, which events could result in an acceleration of some or all 
      of our outstanding debt as a result of cross-default provisions;

*     Increasing our vulnerability to general adverse economic and industry 
      conditions;

*     Limiting our ability to obtain additional debt or equity financing;

*     Requiring the dedication of a substantial portion of our cash flow 
      from operations to service our debt, thereby reducing the amount of 
      our cash flow available for other purposes, including capital 
      expenditures;

*     Requiring us to sell debt or equity securities or to sell some of our 
      core assets, possibly on unfavorable terms, to meet payment 
      obligations;

*     Limiting our flexibility in planning for, or reacting to, changes in 
      our business and the industries in which we compete; and

*     Placing us at a possible competitive disadvantage with less leveraged 
      competitors and competitors that may have better access to capital 
      resources.

Our credit agreement contains restrictive covenants that could adversely 
affect our business by limiting our flexibility.

Our credit agreement imposes restrictions that affect, among other things, 
our ability to incur additional debt, pay dividends, sell assets, create 
liens, make capital expenditures and investments, merge or consolidate, 
enter into transactions with affiliates, and otherwise enter into certain 
transactions outside the ordinary course of business.  Our credit agreement 
also requires us to maintain specified financial ratios and meet certain 
financial tests.  Our ability to continue to comply with these covenants 
and restrictions may be affected by events beyond our control.  A breach of 
any of these covenants or restrictions would result in an event of default 
under our credit agreement.  Upon the occurrence of a breach, the lender 
under our credit agreement could elect to declare all amounts borrowed 
thereunder, together with accrued interest, to be due and payable, 
foreclose on the assets securing our credit agreement and/or cease to 
provide additional revolving loans or letters of credit, which would have a 
material adverse effect on us.

We have incurred losses in each of the last three years, and we may 
continue to incur losses.

We have incurred net losses in the recently completed nine months ended 
March 31, 2005, as well as each of the last three fiscal years.  We had net 
losses of $4.5 million in the nine months ended March 31, 2005, $8.2 


  33


million in fiscal year 2004, $19.5 million in fiscal year 2003 and $10.4 
million in fiscal year 2002.  Our operations may not be profitable in the 
future.

If we cannot obtain additional financing when needed, we may not be able to 
expand our operations and invest adequately in research and development, 
which could cause us to lose customers and market share.

The development and manufacturing of flexible interconnects is capital 
intensive.  To remain competitive, we must continue to make significant 
expenditures for capital equipment, expansion of operations and research 
and development.  We expect that substantial capital will be required to 
expand our manufacturing capacity and fund working capital for anticipated 
growth.  We may need to raise additional funds either through borrowings or 
further equity financing.  We may not be able to raise additional capital 
on reasonable terms, or at all.  If we cannot raise the required funds when 
needed, we may not be able to satisfy the demands of existing and 
prospective customers and may lose revenue and market share.

Our operating results fluctuate and may fail to satisfy the expectations of 
public market analysts and investors, causing our stock price to decline.

Our operating results have fluctuated significantly in the past and we 
expect our results to continue to fluctuate in the future.  Our results may 
fluctuate due to a variety of factors, including the timing and volume of 
orders from customers, the timing of introductions of and market acceptance 
of new products, changes in prices of raw materials, variations in 
production yields and general economic trends.  It is possible that in some 
future periods our results of operations may not meet or exceed the 
expectations of public market analysts and investors.  If this occurs, the 
price of our common stock is likely to decline.

Our quarterly results depend upon a small number of large orders received 
in each quarter, so the loss of any single large order could adversely 
impact quarterly results and cause our stock price to drop.

A substantial portion of our sales in any given quarter depends on 
obtaining a small number of large orders for products to be manufactured 
and shipped in the same quarter in which the orders are received.  Although 
we attempt to monitor our customers' needs, we often have limited knowledge 
of the magnitude or timing of future orders.  It is difficult for us to 
reduce spending on short notice on operating expenses such as fixed 
manufacturing costs, development costs and ongoing customer service.  As a 
result, a reduction in orders, or even the loss of a single large order, 
for products to be shipped in any given quarter could have a material 
adverse effect on our quarterly operating results.  This, in turn, could 
cause our stock price to decline.

Because we sell a substantial portion of our products to a limited number 
of customers, the loss of a significant customer or a substantial reduction 
in orders by any significant customer would adversely impact our operating 
results.

Historically we have sold a substantial portion of our products to a 
limited number of customers.  Our 20 largest customers based on sales 
accounted for approximately 52% of total revenues in fiscal year 2004, 50% 
of total revenues in fiscal year 2003, and 44% in fiscal year 2002.

We expect that a limited number of customers will continue to account for a 
high percentage of our total revenues in the foreseeable future.  As a 
result, the loss of a significant customer or a substantial reduction in 
orders by any significant customer would cause our revenues to decline and 
have an adverse effect on our operating results.


  34


If we are unable to respond effectively to the evolving technological 
requirements of customers, our products may not be able to satisfy the 
demands of existing and prospective customers and we may lose revenues and 
market share.

The market for our products is characterized by rapidly changing technology 
and continuing process development.  The future success of our business 
will depend in large part upon our ability to maintain and enhance our 
technological capabilities.  We will need to develop and market products 
that meet changing customer needs, and successfully anticipate or respond 
to technological changes on a cost-effective and timely basis.  There can 
be no assurance that the materials and processes that we are currently 
developing will result in commercially viable technological processes, or 
that there will be commercial applications for these technologies. In 
addition, we may not be able to make the capital investments required to 
develop, acquire or implement new technologies and equipment that are 
necessary to remain competitive.  If we fail to keep pace with 
technological change, our products may become less competitive or obsolete 
and we may lose customers and revenues.

Competing technologies may reduce demand for our products.

Flexible circuit and laminated cable interconnects provide electrical 
connections between components in electrical systems and are used as a 
platform to support the attachment of electronic devices. While flexible 
circuits and laminated cables offer several advantages over competing 
printed circuit board and ceramic hybrid circuit technologies, our 
customers may consider changing their designs to use these alternative 
technologies in future applications.  If our customers switch to 
alternative technologies, our business, financial condition and results of 
operations could be materially adversely affected.  It is also possible 
that the flexible interconnect industry could encounter competition from 
new technologies in the future that render existing flexible interconnect 
technology less competitive or obsolete.

We are heavily dependent upon certain target markets for domestic 
manufacturing. A slowdown in these markets could have a material impact on 
domestic capacity utilization resulting in lower sales and gross margins.

We manufacture our products in seven facilities worldwide, including lower 
cost offshore locations in China.  However, a significant portion of our 
manufacturing is still performed domestically.  Domestic manufacturing may 
be at a competitive disadvantage with respect to price when compared to 
lower cost facilities in Asia and other locations.  While historically our 
competitors in these locations have produced less technologically advanced 
products, they continue to expand their capabilities.  Further, we have 
targeted markets that have historically sought domestic manufacturing, 
including the military and aerospace markets.  Should we be unsuccessful in 
maintaining our competitive advantage or should certain target markets also 
move production to lower cost offshore locations, our domestic sales will 
decline resulting in significant excess capacity and reduced gross margins.

A significant downturn in any of the sectors in which we sell products 
could result in a revenue shortfall.

We sell our flexible interconnect products principally to the automotive, 
telecommunications and networking, diversified electronics, military, home 
appliance, electronic identification and computer markets.  The worldwide 
electronics industry has seen a substantial downturn since 2001 impacting a 
number of our target markets.  Although we serve a variety of markets to 
avoid a dependency on any one sector, a significant further downturn in any 
of these market sectors could cause a material reduction in our revenues, 
which could be difficult to replace.


  35


We rely on a limited number of suppliers, and any interruption in our 
primary sources of supply, or any significant increase in the prices of 
materials, chemicals or components, would have an adverse effect on our 
short-term operating results.

We purchase the bulk of our raw materials, process chemicals and components 
from a limited number of outside sources. In fiscal year 2004, we purchased 
approximately 21% of our materials from Tongxing, a Chinese gold plater, 
and Northfield Acquisition Co., doing business as Sheldahl, our two largest 
suppliers. We operate under tight manufacturing cycles with a limited 
inventory of raw materials.  As a result, although there are alternative 
sources of the materials that we purchase from our existing suppliers, any 
unanticipated interruption in supply from Tongxing or Sheldahl, or any 
significant increase in the prices of materials, chemicals or components, 
would have an adverse effect on our short-term operating results.

The additional expenses and risks related to our existing international 
operations, as well as any expansion of our global operations, could 
adversely affect our business.

We own a 90.1% equity interest in our investment in China, Parlex Shanghai, 
which manufactures and sells flexible circuits.  We also operate a facility 
in Mexico for use in the finishing, assembly and testing of flexible 
circuit and laminated cable products.  We have a facility in the United 
Kingdom where we manufacture polymer thick film flexible circuits and 
polymer thick film flexible circuits with surface mounted components and 
intend to introduce production of laminated cable within the next year.  We 
will continue to explore appropriate expansion opportunities as demand for 
our products increases.

Manufacturing and sales operations outside the United States carry a number 
of risks inherent in international operations, including: imposition of 
governmental controls, regulatory standards and compulsory licensure 
requirements; compliance with a wide variety of foreign and U.S. import and 
export laws; currency fluctuations; unexpected changes in trade 
restrictions, tariffs and barriers; political and economic instability; 
longer payment cycles typically associated with foreign sales; difficulties 
in administering business overseas; foreign labor issues; wars and acts of 
terrorism; and potentially adverse tax consequences.  Although these issues 
have not materially impacted our revenues or operations to date, we cannot 
guarantee that they will not impact our revenues or operations in the 
future.

International expansion may require significant management attention, which 
could negatively affect our business.  We may also incur significant costs 
to expand our existing international operations or enter new international 
markets, which could increase operating costs and reduce our profitability.

We face significant competition, which could make it difficult for us to 
acquire and retain customers.

We face competition worldwide in the flexible interconnect market from a 
number of foreign and domestic providers, as well as from alternative 
technologies such as rigid printed circuits.  Many of our competitors are 
larger than we are and have greater financial resources.  New competitors 
could also enter our markets.  Our competitors may be able to duplicate our 
strategies, or they may develop enhancements to, or future generations of, 
products that could offer price or performance features that are superior 
to our products.  Competitive pressures could also necessitate price 
reductions, which could adversely affect our operating results.  In 
addition, some of our competitors are based in foreign countries and have 
cost structures and prices based on foreign currencies.  Accordingly, 
currency fluctuations could cause our dollar-priced products to be less 
competitive than our competitors' products priced in other currencies.

We will need to make a continued high level of investment in product 
research and development, sales and marketing and ongoing customer service 
and support in order to remain competitive.  We may not have sufficient 
resources to be able to make these investments.  Moreover, we may not be 
able to make the technological advances necessary to maintain our 
competitive position in the flexible interconnect market.


  36


We face risks from fluctuations in the value of foreign currency versus the 
U.S. dollar and the cost of currency exchange. 

While we transact business predominantly in U.S. dollars, a large portion 
of our sales and expenses are denominated in foreign currencies, primarily 
the Chinese Renminbi ("RMB"), the basic unit of currency issued by the 
People's Bank of China.  Currently, our exposure to risk from foreign 
exchange is limited due to the fact that the People's Republic of China has 
fixed the exchange rate of the Renminbi to the U.S. dollar.  The value of 
the Renminbi is subject to changes in the PRC government's policies and 
depends to an extent on its domestic and international economic and 
political developments, as well as supply and demand in the local market.  
We cannot give any assurance that the Renminbi will continue to remain 
stable against the U.S. dollar and other foreign currencies.  Any 
devaluation of the Renminbi may adversely affect our results of operations.  
In addition, a small portion of our sales and expenses are denominated in 
Euros and the British Pound.  Changes in the relation of foreign currencies 
to the U.S. dollar will affect our cost of sales and operating margins and 
could result in exchange losses.  We do not enter into foreign exchange 
contracts to reduce our exposure to these risks. 

If we are unable to attract, retain and motivate key personnel, we may not 
be able to develop, sell and support our products and our business may lack 
strategic direction.

We are dependent upon key members of our management team.  In addition, our 
future success will depend in large part upon our continuing ability to 
attract, retain and motivate highly qualified managerial, technical and 
sales personnel.  Competition for such personnel is intense, and there can 
be no assurance that we will be successful in hiring or retaining such 
personnel.  We currently maintain a key person life insurance policy in the 
amount of $1.0 million on Peter J. Murphy. If we lose the services of Mr. 
Murphy or one or more other key individuals, or are unable to attract 
additional qualified members of the management team, our ability to 
implement our business strategy may be impaired. If we are unable to 
attract, retain and motivate qualified technical and sales personnel, we 
may not be able to develop, sell and support our products.

If we are unable to protect our intellectual property, our competitive 
position could be harmed and our revenues could be adversely affected.

We rely on a combination of patent and trade secret laws and non-disclosure 
and other contractual agreements to protect our proprietary rights.  We own 
17 patents issued and have 7 patent applications pending in the United 
States and have several corresponding foreign patent applications pending. 
Our existing patents may not effectively protect our intellectual property 
and could be challenged by third parties, and our future patent 
applications, if any, may not be approved.  In addition, other parties may 
independently develop similar or competing technologies. Competitors may 
attempt to copy aspects of our products or to obtain and use information 
that we regard as proprietary.  If we fail to adequately protect our 
proprietary rights, our competitors could offer similar products using 
materials, processes or technologies developed by us, potentially harming 
our competitive position and our revenues.

If we become involved in a protracted intellectual property dispute, or one 
with a significant damages award or which requires us to cease selling some 
of our products, we could be subject to significant liability and the time 
and attention of our management could be diverted.

Although no claims have been asserted against us for infringement of the 
proprietary rights of others, we may be subject to a claim of infringement 
in the future.  An intellectual property lawsuit against us, if successful, 
could subject us to significant liability for damages and could invalidate 
our proprietary rights.  A successful lawsuit against us could also force 
us to cease selling, or redesign, products that incorporate the infringed 
intellectual property.  We could also be required to obtain a license from 
the holder of the intellectual property to use the infringed technology.  
We might not be able to obtain a license on reasonable


  37


terms, or at all.  If we fail to develop a non-infringing technology on a 
timely basis or to license the infringed technology on acceptable terms, 
our revenues could decline and our expenses could increase.

We may, in the future, be required to initiate claims or litigation against 
third parties for infringement of our proprietary rights or to determine 
the scope and validity of our proprietary rights or the proprietary rights 
of competitors.  Litigation with respect to patents and other intellectual 
property matters could result in substantial costs and divert our 
management's attention from other aspects of our business.

Market prices of technology companies have been highly volatile, and our 
stock price may be volatile as well.

From time to time the U.S. stock market has experienced significant price 
and trading volume fluctuations, and the market prices for the common stock 
of technology companies in particular have been extremely volatile.  In the 
past, broad market fluctuations that have affected the stock price of 
technology companies have at times been unrelated or disproportionate to 
the operating performance of these companies.  Any significant fluctuations 
in the future might result in a material decline in the market price of our 
common stock.

Following periods of volatility in the market price of a particular 
company's securities, securities class action litigation has often been 
brought against that company.  If we were to become involved in this type 
of litigation, we could incur substantial costs and diversion of 
management's attention, which could harm our business, financial condition 
and operating results.

The costs of complying with existing or future environmental regulations, 
and of curing any violations of these regulations, could increase our 
operating expenses and reduce our profitability.

We are subject to a variety of environmental laws relating to the storage, 
discharge, handling, emission, generation, manufacture, use and disposal of 
chemicals, solid and hazardous waste and other toxic and hazardous 
materials used to manufacture, or resulting from the process of 
manufacturing, our products.  We cannot predict the nature, scope or effect 
of future regulatory requirements to which our operations might be subject 
or the manner in which existing or future laws will be administered or 
interpreted.  Future regulations could be applied to materials, products or 
activities that have not been subject to regulation previously.  The costs 
of complying with new or more stringent regulations, or with more vigorous 
enforcement of these regulations, could be significant.

Environmental laws require us to maintain and comply with a number of 
permits, authorizations and approvals and to maintain and update training 
programs and safety data regarding materials used in our processes.  
Violations of these requirements could result in financial penalties and 
other enforcement actions.  We could also be required to halt one or more 
portions of our operations until a violation is cured. Although we attempt 
to operate in compliance with these environmental laws, we may not succeed 
in this effort at all times.  The costs of curing violations or resolving 
enforcement actions that might be initiated by government authorities could 
be substantial.

Undetected problems in our products could directly impair our financial 
results.

If flaws in design, production, assembly or testing of our products were to 
occur by us or our suppliers, we could experience a rate of failure in our 
products that would result in substantial repair or replacement costs and 
potential damage to our reputation.  Continued improvement in manufacturing 
capabilities, control of material and manufacturing quality, and costs and 
product testing, are critical factors in our future growth.  There can be 
no assurance that our efforts to monitor, develop, modify and implement 
appropriate test and manufacturing processes for our products will be 
sufficient to permit us to avoid a rate of failure in our products that 
results in substantial delays in shipment, significant repair or 
replacement costs, or potential


  38


damage to our reputation, any of which could have a material adverse effect 
on our business, results of operations or financial condition.

Our stock is thinly traded.

Our stock is thinly traded and you may have difficulty in reselling your 
shares quickly.  The low trading volume of our common stock is outside of 
our control, and we cannot guarantee that trading volume will increase in 
the near future.

We do not expect to pay dividends in the foreseeable future.

We have never paid cash dividends on our common stock and we do not expect 
to pay cash dividends on our common stock any time in the foreseeable 
future.  In addition, our current financing agreements prohibit the payment 
of dividends.  The future payment of dividends directly depends upon our 
future earnings, capital requirements, financial requirements and other 
factors that our board of directors will consider.  For the foreseeable 
future, we will use earnings from operations, if any, to finance our 
growth, and we will not pay dividends to our common stockholders.  You 
should not rely on an investment in our common stock if you require 
dividend income.  The only return on your investment in our common stock, 
if any, would most likely come from any appreciation of our common stock. 

We may have exposure to additional income tax liabilities.

As a multinational corporation, we are subject to income taxes in both the 
United States and various foreign jurisdictions. Our domestic and 
international tax liabilities are subject to the allocation of revenues and 
expenses in different jurisdictions and the timing of recognizing revenues 
and expenses. Additionally, the amount of income taxes paid is subject to 
our interpretation of applicable tax laws in the jurisdictions in which we 
file.  From time to time, we are subject to income tax audits.  While we 
believe we have complied with all applicable income tax laws, there can be 
no assurance that a governing tax authority will not have a different 
interpretation of the law and assess us with additional taxes.  Should we 
be assessed with significant additional taxes, there could be a material 
adverse affect on our results of operations or financial condition.

We could use preferred stock to resist takeovers, and the issuance of 
preferred stock may cause additional dilution.

Our Articles of Organization authorizes the issuance of up to 1,000,000 
shares of preferred stock, of which 40,625 shares are issued and 
outstanding as a result of our preferred stock offering completed in June 
2004.  Our Articles of Organization gives our board of directors the 
authority to issue preferred stock without approval of our stockholders. We 
may issue additional shares of preferred stock to raise money to finance 
our operations. We may authorize the issuance of the preferred stock in one 
or more series.  In addition, we may set the terms of preferred stock, 
including:

*     dividend and liquidation preferences;

*     voting rights;

*     conversion privileges;

*     redemption terms; and

*     other privileges and rights of the shares of each authorized series.

The issuance of large blocks of preferred stock could possibly have a 
dilutive effect to our existing stockholders.  It can also negatively 
impact our existing stockholders' liquidation preferences.  In addition, 


  39


while we include preferred stock in our capitalization to improve our 
financial flexibility, we could possibly issue our preferred stock to 
friendly third parties to preserve control by present management.  This 
could occur if we become subject to a hostile takeover that could 
ultimately benefit Parlex and Parlex's stockholders.

Item 3.  Quantitative and Qualitative Disclosures About Market Risk
-------------------------------------------------------------------

The following discussion about our market risk disclosures involves forward-
looking statements. Actual results could differ materially from those 
projected in the forward-looking statements. 

We are exposed to market risk related to changes in U.S. and foreign interest 
rates and fluctuations in exchange rates. We do not use derivative financial 
instruments.

Interest Rate Risk

Our primary bank facility bears interest at our lender's prime rate plus 
2.0%.  We also have two subsidiary bank notes at LIBOR plus 2.5% and LIBOR 
plus 2.0%.  The prime rate is affected by changes in market interest rates.  
These variable rate lending facilities create exposure for us relating to 
interest rate risk; however, we do not believe our interest rate risk to be 
material.  As of March 31, 2005, we had an outstanding balance under our 
primary bank facility of $3,951,000 and an outstanding balance of $3,251,000 
under our subsidiary note.  A hypothetical 10% change in interest rates would 
impact interest expense by approximately $45,000 over the next fiscal year, 
and such amount would not have a material effect on our financial position, 
results of operations and cash flows. 

The remainder of our long-term debt bears interest at fixed rates and is 
therefore not subject to interest rate risk. 

Currency Risk

Sales of Parlex Shanghai, Parlex Interconnect, Parlex (Shanghai) Interconnect 
Technologies ("Parlex Technologies"), Poly-Flex Circuits Limited and Parlex 
Europe are typically denominated in the local currency, which is also each 
company's functional currency.  This creates exposure to changes in exchange 
rates.  The changes in the Chinese/U.S. and U.K./U.S. exchange rates may 
positively or negatively impact our sales, gross margins and retained 
earnings. Based upon the current volume of transactions in China and the 
United Kingdom and the stable nature of the exchange rate between China and 
the U.S., we do not believe the market risk is material.  We do not engage in 
regular hedging activities to minimize the impact of foreign currency 
fluctuations.  Parlex Shanghai, Parlex Interconnect and Parlex Technologies 
had combined net assets as of March 31, 2005 of approximately $22.4 million.  
Poly-Flex Circuits Limited and Parlex Europe had combined net assets as of 
March 31, 2005 of approximately $6.1 million.  We believe that a 10% change 
in exchange rates would not have a significant impact upon our financial 
position, results of operation or outstanding debt.  As of March 31, 2005, 
Parlex Shanghai and Parlex Interconnect had combined outstanding debt of 
approximately $8.3 million.  As of March 31, 2005, Poly-Flex Circuits Limited 
had no outstanding debt. 

Item 4.  Controls and Procedures
--------------------------------

Evaluation of Disclosure Controls and Procedures 

We maintain disclosure controls and procedures that are designed to ensure 
that information required to be disclosed in the reports that we are 
required to file under the Securities and Exchange Act of 1934 is recorded, 
processed, summarized and reported within the time periods specified in the 
SEC's rules and forms, and that such information is accumulated and 
communicated to our management, including our principal executive officer 
and our principal financial officer, as appropriate, to allow timely 
decisions regarding required disclosure.  Management necessarily applied 
its judgment in assessing the costs and benefits of such controls and 
procedures, which, by their nature, can provide only reasonable assurance 


  40


regarding management's control objectives.  Management believes that there 
are reasonable assurances that our controls and procedures will achieve 
management's control objectives. 

We have carried out an evaluation, under the supervision and with the 
participation of our management, including our Chief Executive Officer and 
our Chief Financial Officer, of the effectiveness of the design and 
operation of our disclosure controls and procedures pursuant to Exchange 
Act Rule 13a-15 as of March 31, 2005.  Based upon the foregoing, our Chief 
Executive Officer and our Chief Financial Officer concluded that our 
disclosure controls and procedures are effective in timely alerting them to 
material information relating to our Company (and its consolidated 
subsidiaries) required to be included in our Exchange Act reports. 

Changes in Internal Controls Over Financial Reporting 

There have been no changes in our internal control over financial reporting 
during our most recent fiscal quarter that have materially affected, or are 
reasonably likely to materially affect, our internal control over financial 
reporting.


  41


                         PART II - OTHER INFORMATION
                         ---------------------------

Item 3.  Defaults Upon Senior Securities

         As of March 31, 2005, we were not in compliance with our EBITDA 
         financial covenant under our Loan Agreement with Silicon Valley 
         Bank.  Although the bank could have called for early repayment of 
         the debt, no such demand was made.  We have received a waiver from 
         the bank for our non-compliance at March 31, 2005.

Item 6.  EXHIBITS

         Exhibits - See Exhibit Index to this report.


  42


                                 SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the 
registrant has duly caused this report to be signed on its behalf by the 
undersigned thereunto duly authorized.


                                  PARLEX CORPORATION
                                  ------------------


                                  By: /s/ Peter J. Murphy
                                      -------------------------------------
                                      Peter J. Murphy
                                      President and Chief Executive Officer


                                  By: /s/ Jonathan R. Kosheff
                                      -------------------------------------
                                      Jonathan R. Kosheff
                                      Treasurer & CFO

                                  (Principal Accounting and Financial Officer)


                                                   May 13, 2005
                                                   ------------
                                                       Date


  43


                                EXHIBIT INDEX

EXHIBIT    DESCRIPTION OF EXHIBIT
-------    -----------------------

  10.1     Eighth Loan Modification Agreement, dated May 10, 2005 by and 
           between Parlex Corporation and Silicon Valley Bank.  (filed 
           herewith)

  10.2     First Amendment to Lease, dated June 29, 2004, by and between 
           Taurus Methuen LLC, as landlord, and Parlex Corporation, as 
           tenant.  (filed herewith)

  10.3     Second Amendment to Lease, dated February 18, 2005, by and 
           between Taurus Methuen LLC, as landlord, and Parlex Corporation, 
           as tenant.  (filed herewith)

  10.4     First Amendment to Joint Venture Agreement, dated March 28, 
           2005, by and between Parlex Asia Pacific Ltd and Infineon 
           Technologies Asia Pacific Pte. Ltd.  (filed herewith)

  31.1     Certification of Registrant's Chief Executive Officer required 
           by Rule 13a-14(a) (filed herewith)

  31.2     Certification of Registrant's Chief Financial Officer required 
           by Rule 13a-14(a) (filed herewith)

  32.1     Certification of Registrant's Chief Executive Officer pursuant 
           To 18 U.S.C. 1350 (furnished herewith)

  32.2     Certification of Registrant's Chief Financial Officer pursuant 
           To 18 U.S.C. 1350 (furnished herewith)


  44